IRVINE, CA–(Marketwire – September 23, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) (“Sun”) announced today that it intends to refinance its existing senior secured credit facilities with borrowings under a new senior secured credit facility to be entered into by SHG Services, Inc., a subsidiary of Sun (“SHG”). The new senior secured facility is expected to include a $60 million revolving credit facility, a $150 million term loan and a $75 million funded letter of credit facility. The refinancing, which is being undertaken in connection with Sun’s previously announced restructuring, is subject to market and other conditions, and there can be no assurances that these transactions will be consummated.

About Sun Healthcare Group, Inc.

Sun’s subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary.

In May 2010, Sun announced a plan to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies through a series of internal restructurings (the “Restructuring”), subject to the approval of stockholders and other conditions. In connection with the Restructuring, SHG will own and continue to operate all of Sun’s operating subsidiaries, with stockholders of Sun receiving a pro rata distribution of the stock of SHG (the “Separation”). Substantially all of Sun’s currently-owned real estate assets will be owned by Sabra Health Care REIT, Inc., a subsidiary of Sun (“Sabra”) and, immediately after the Separation, Sun will merge into Sabra. Following this merger, SHG will change its name to Sun Healthcare Group, Inc. The common stock of both companies is expected to trade on the NASDAQ Global Select Market. The Restructuring (including the Separation) is expected to be completed in the fourth quarter of 2010.

Forward-Looking Statement

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Forward-looking statements in this release include all statements regarding our expected future financial position and results of operations, business strategy, the impact of reductions in reimbursements and other changes in government reimbursement programs, the timing and impact of the Separation and transactions related thereto, growth opportunities and plans and objectives of management for future operations. Factors that could cause actual results to differ are identified in the public filings made by Sun with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements; the impact that any healthcare reform legislation will have on our business; our ability to maintain the occupancy rates and payor mix at our healthcare centers; potential liability for losses not covered by, or in excess of, our insurance; the effects of government regulations and investigations; the significant amount of our indebtedness, covenants in our debt agreements that may restrict our activities and our ability to make acquisitions, to incur more indebtedness and to refinance indebtedness on favorable terms; our ability to accomplish the Separation and the transactions related thereto, the impact of the current economic downturn on our business; increasing labor costs and the shortage of qualified healthcare personnel; and our ability to receive increases in reimbursement rates from government payors to cover increased costs. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Forms 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. There may be additional risks of which we are presently unaware or that we currently deem immaterial.

The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance and are only made as of the date of this release. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

Additional Information

In connection with the Separation, SHG has filed with the SEC a Registration Statement on Form S-1 and Sabra has filed with the SEC a Registration Statement on Form S-4, each containing an identical proxy statement/prospectus. The definitive proxy statement/prospectus will be mailed to Sun stockholders. Before making any voting or investment decision, Sun stockholders and investors are urged to read the proxy statement/prospectus and other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about the proposed transactions. Stockholders will be able to obtain these documents free of charge at the SEC’s web site at www.sec.gov. In addition, investors and stockholders of Sun may obtain free copies of the documents filed with the SEC by contacting Sun’s investor relations department at (505) 468-2341 (TDD users, please call (505) 468-4458) or by sending a written request to Investor Relations, Sun Healthcare Group, Inc. 101 Sun Avenue N.E., Albuquerque, N.M. 87109.

Sun and its directors and executive officers and other members of its management and employees may be deemed to be participants in the solicitation of proxies from the stockholders of Sun in connection with the transactions described in this release. Information about the directors and executive officers of Sun and their ownership of shares of Sun common stock are set forth in the Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 5, 2010, and in the definitive proxy statement relating to Sun’s 2010 Annual Meeting of Stockholders filed with the SEC on April 30, 2010. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants will also be included in the definitive proxy statement/prospectus when it becomes available.

TAMPA, FL–(Marketwire – September 23, 2010) –  Bacteria breakouts that are surviving the best antibiotics available are spreading across the U.S. at an alarming rate, according to infectious disease experts. 

“Bugs, superbugs, MRSA (methicillin-resistant Staphylococcus aureus) and KPC (Klebsiella pneumoniae carbapenamase) have cropped up in germ-infested health clubs, gyms and even dirty hospitals,” says Dr. Brad Spellberg, infectious disease specialist, scientist, author and researcher at the David Geffen School of Medicine at UCLA and Harbor/UCLA Medical Center in Los Angeles. “Our industry is not developing any new antibiotics to combat this medical urgency.”

Spellberg, a recognized expert on the topic of antibiotic-resistant germs, and other physicians expressed alarm at the lack of antibiotics currently in development while testifying this past June during a U.S. House Energy and Commerce Health Subcommittee special hearing.

Dr. Spellberg, and other physicians who testified, raised concern for the spread of antibiotic-resistant microbes, including out of the hospital and into the community — with lethal results. 

“Everyone is at risk of these infections,” warned Dr. Spellberg, who spoke on behalf of the Infectious Diseases Society of America. Dr. Spellberg is also a member of the Advisory Board of Zimek Technologies, a worldwide leader in infection control and biohazard remediation which has been developing and marketing its proven patented automatic Micro-Mist^® decontamination technologies for more than five years.

Zimek’s industry-leading technologies are used by the U.S. Department of Homeland Security, Department of Defense, Fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities, and local law enforcement agencies across America. Zimek’s special products “micronize” disinfectants that can quickly and automatically decontaminate facilities, equipment and vehicles. Zimek’s germ-killing, revolutionary “micro-mist” can permeate crevasses and hidden surfaces where super-germs are untouched by standard sanitizing methods.

A dangerous new “superbug” gene created more attention last week. Labeled New Delhi metallo-beta-lactamase, better known as NDM-1, it is a resistant gene proliferating in particular “superbugs” which have the potential of spreading around the world, and scientists say there are almost no drugs in the pipeline to treat it.

Antibiotic-resistant infections “are extremely difficult to treat and frequently recur,” Spellberg said. “These infections result in tremendous pain, suffering and disfigurement in adults, children and infants, and have caused millions of deaths worldwide.”

Nearly 100,000 Americans die annually from infections acquired in hospitals, and treatment-resistant strains are spreading into our health clubs and gyms, Spellberg added.

“Zimek’s proven rapid infection control application is a meaningful 21^st century best practices infection prevention technology which will add another weapon to our arsenal to combat the spread of infectious diseases,” said Kurt Grosman, CEO of Zimek Technologies. 

Spellberg, who is on the frontlines of the infectious disease battle, will discuss these concerns in a special investigative news story on the “CBS Evening News with Katie Couric” scheduled for broadcast on September 27^th and 28^th. (Please visit www.zimek.com for exact airdate/time.)

Spellberg will also be interviewed on an upcoming episode of “The Doctors,” the award-winning syndicated talk show airing daily in the U.S., Canada, Mexico, Ireland, Sweden and Finland. “The Doctors” is distributed domestically and worldwide by CBS Television Distribution. (Please visit www.zimek.com for exact airdate/time.)

WASHINGTON, DC–(Marketwire – September 23, 2010) –  Today, Lance Armstrong, LIVESTRONG(R) founder and chairman, cancer survivor and champion cyclist, made a surprise visit to the pediatric oncology unit at Children’s National Medical Center. He was joined by John R. Seffrin, PhD, chief executive officer of the American Cancer Society, to meet with hospital administrators, doctors and young patients and their families.

Today marks the six month anniversary of the Affordable Care Act. Starting today, several critical provisions of the law begin to take effect. Under the new law, healthcare plan providers cannot discriminate against children with pre-existing conditions. More than nine million children in the United States are currently living without health insurance. Up to 72,000 uninsured children with pre-existing conditions could gain coverage as a result of the new reform.

“Parents already feel the weight of the world on their shoulders when a child is diagnosed with cancer,” said Armstrong. “Insurance and health costs shouldn’t serve as a barrier to receiving quality, timely treatment. I’m hopeful that this reform will save lives and improve the quality of life for the more than 270,000 childhood cancer survivors currently living in the United States.”

“The Affordable Care Act is providing critical protections that are expanding access to lifesaving health care to children and adults with cancer or at risk of cancer,” said Seffrin. “Important provisions taking effect today prohibit health plans from denying coverage to children up to age 19 with pre-existing conditions such as cancer, and enable dependent children to remain on their parent’s insurance policy up to age 26.”

“With advances and breakthroughs in therapy, approximately 75% of children with cancer are cured of their disease. Nevertheless, cancer remains the leading cause of non-accidental death in children in the United States and many survivors suffer from chronic conditions that result from their treatment. Children’s National Medical Center is proud to be a leader in the search for novel treatments that will increase cure rates while decreasing adverse effects,” said Jeffrey S. Dome, MD, PhD; Chief, Division of Oncology; Center for Cancer and Blood Disorders; Children’s National Medical Center.

Armstrong’s visit also falls during National Childhood Cancer Awareness Month, a time to increase awareness and encourage support for the children and families affected by the disease. Cancer is currently the leading cause of death by disease among U.S. children between infancy and age 15, and it is estimated that 10,730 new cases of pediatric cancer were diagnosed in children 0-14 years of age in 2009. Two-thirds of childhood cancer survivors face at least one chronic health condition later in life and one quarter of survivors face a late effect from treatment that is severe or life threatening.

LIVESTRONG, the organization Armstrong established to support fellow cancer survivors and their families, offers a multitude of resources to help pediatric cancer survivors and their families manage the long-term effects of childhood cancers. The organization recently helped establish the LIVESTRONG Childhood Cancer Survivorship Center at Dell Children’s Medical Center in Austin, Texas. The Center aims to improve the health and well-being of childhood cancer survivors by promoting adherence to a schedule of follow-up appointments; providing referrals to specialists; offering psychosocial support groups; transitioning patients to adult care when they are ready; and educating patients, parents and healthcare professionals about the long-term effects of cancer treatment.

LIVESTRONG SurvivorCare also offers specialized resources that focus on the needs of cancer survivors, including children. The free resource, available in English and Spanish, provides survivors and their families with emotional support; individual counseling; financial and legal advice, including finding assistance for the uninsured or underinsured; and matching to clinical trials.

About LIVESTRONG
Founded in 1997 by cancer survivor and champion cyclist Lance Armstrong and based in Austin, Texas, LIVESTRONG fights for the 28 million people around the world living with cancer today. LIVESTRONG connects individuals to the support they need, leverages funding and resources to spur innovation and engages communities and leaders to drive social change. Known for the iconic yellow wristband, LIVESTRONG‘s mission is to inspire and empower anyone affected by cancer. For more information, visit www.LIVESTRONG.org.

About Children’s National Medical Center
Children’s National Medical Center in Washington, DC, has been serving the nation’s children since 1870. Home to Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is consistently ranked among the top pediatric hospitals by U.S. News & World Report and the Leapfrog Group. With 283 beds, more than 1,330 nurses, 550 physicians, and seven regional outpatient centers, Children’s National is the only exclusive provider of pediatric care in the Washington metropolitan area. Children’s National has been recognized by the American Nurses Credentialing Center as a Magnet® designated hospital, the highest level of recognition for nursing excellence that a medical center can achieve. For more information, visit www.ChildrensNational.org.

WEST HARTFORD, CT–(Marketwire – September 23, 2010) –  ORLive, the leader in online medical video, presents a live interactive broadcast of a hip replacement surgery featuring technology from Zimmer. On-demand features this month include our library of procedures and educational programming focused on atrial fibrillation. Additionally, ORLive invites you to take part in the latest installment of the Virtual Brain Tumor Board.

NEW ON ORLIVE

LIVE SURGERY VIDEO – Continuum® Acetabular System and Zimmer® M/L Taper with Kinectiv® Technology
Premieres Thursday, September 23, 2010 at 7PM EDT

On Thursday, September 23rd at 7 PM EDT Zimmer Medical Education will broadcast an ORLive Total Hip Arthroplasty featuring the Continuum Acetabular System and the Kinectiv Modular Neck Technology. The surgery will be performed by Dr. Mark Hartzband, Hartzband Center for Hip and Knee Replacement, L.L.C., Paramus, NJ and will be moderated by Dr. Paul Duwelius, St. Vincent Hospital, Portland, OR. The broadcast will last one hour and will show the entire surgical procedure. Following the live broadcast the surgery will be archived for future playback.

This opportunity allows for firsthand insight of the safe and effective implantation and surgical procedure involved with the Continuum® Acetabular System and the Zimmer® M/L Taper with Kinectiv® Technology.

This surgery video is available exclusively to members of the ORLive community, and members can interact and ask questions via the ORLive website. Learn more about this broadcast or get a reminder at ORLive.com, and be ready to view this exciting procedure by activating your free membership to ORLive today.

NOW ON-DEMAND – Artificial Disc Treatments for Cervical Disease
Now Available On-Demand

Until recently, spinal fusion was the surgical solution to cervical disc disease. ORLive invites you to watch footage of an Artificial Discectomy performed by William Kuhn, MD of Halifax Hospital, and join in on a live online discussion with the doctor and patient, Ali Rabatsky. 

Viewers of this video are invited to interact with the team via the ORLive website, where you can also request a reminder to alert you when this video is going live.

ORLIVE REFERRALS – Week of September 20, 2010
September is National Atrial Fibrillation Awareness Month, and each week ORLive highlights on-demand videos for our membership and visitors. 

Medical Education Referral: Paracardioscopic Ex-Maze, from FirstHealth Moore Regional Hospital

CME Referral: Reality EP: Tackling Left Atrial Tachycardias after Catheter Ablation for AF from the Heart Rhythm Society

Viewer’s Referral: Convergent Procedure for Atrial Fibrillation, from FirstHealth Moore Regional Hospital

HIGHLIGHTS

NOW ON-DEMAND – Surgical and Medical Treatments for Type 2 Diabetes
Now Available On-Demand

Type 2 diabetes can lead to potentially deadly complications for many patients, but the team at NewYork-Presbyterian remains on the forefront of research and treatment innovations. Join Dr. Francesco Rubino, Chief, Gastrointestinal Metabolic Surgery at the Weill Cornell Medical Center, Dr. Judith Korner, from Columbia University Medical Center, and Dr. Louis Aronne, from the Weill Cornell Medical Center as they review the advancements that are being made and see what happens when gastric bypass surgery results in a possible remission of diabetes.

Viewers of this video can still interact with the team via the ORLive website, where you can also request updates as they become available.

PREVIEW – Zimmer Patient Specific Instruments and the Gender Solutions™ Natural-Knee® Flex System
Premieres Tuesday, September 28, 2010 at 7PM EDT

On Tuesday, September 28th at 7 PM EST Zimmer Medical Education will broadcast an ORLive Zimmer Patient Specific Instrument surgery featuring Zimmer Patient Specific Instruments and Natural Knee. The surgery will be performed by Dr. Michael Bolognesi, Duke University Medical Center and will be moderated by Dr. Shawn Hocker from Atlantic Orthopedics, PA in Wilmington, NC. The broadcast will last one hour and will show the entire surgical procedure.

This surgery video is available exclusively to members of the ORLive community, and members can interact and ask questions via the ORLive website. Learn more about this broadcast or get a reminder at ORLive.com, and be ready to view this exciting procedure by activating your free membership to ORLive today.

About ORLive
ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

id=”nav_links”>

ALEXANDRIA, VA–(Marketwire – September 23, 2010) –   Today, the Food and Drug Administration (FDA) announced that it will significantly restrict the use of the diabetes drug Avandia and other drugs containing rosiglitazone to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.

The FDA, in its announcement, noted that it will require GlaxoSmithKline (GSK) to develop a restricted access program for Avandia under a risk evaluation and mitigation strategy (REMS). Under the REMS, Avandia will be available to new patients only if they are unable to achieve glucose control on other medications and are unable to take Actos (pioglitazone), the only other drug in this class. Current users of Avandia who are benefiting from the drug will be able to continue using the medication if they choose to do so. Doctors will have to attest to and document their patients’ eligibility; patients will have to review statements describing the cardiovascular safety concerns associated with this drug and acknowledge they understand the risks. The agency anticipates that the REMS will limit use of Avandia significantly.

The European Medicines Agency (EMA) has suspended the marketing authorization for all rosiglitazone-containing medicines (Avandia, Avandamet® and Avaglim®). These medicines will no longer be available in Europe within the next few months.

The American Diabetes Association, The Endocrine Society and the American Association of Clinical Endocrinologists urge patients who are currently taking Avandia or any combination pill that includes Avandia to contact their diabetes care provider’s office for instructions about treatment options. Patients should be aware that stopping a diabetes medication without consulting a doctor can result in higher levels of blood glucose that may cause serious short term health problems and could increase the risk of long term diabetes-related complications.

Patients and health care professionals should also be aware that multiple classes of drugs, often with more than one agent per class, are available to achieve and maintain glucose control in type 2 diabetes. In order to limit the risk of long-term complications, optimal glucose control, along with control of other risk factors, such as high blood pressure and cholesterol, is critically important for patients with type 2 diabetes. A number of other medications can be used to control diabetes and should be discussed with a patient’s health care team. For more information on the different classes of available medications drugs: http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication/oral-medications/what-are-my-options.html.

The American Diabetes Association, The Endocrine Society, and American Association of Clinical Endocrinologists continue to support the FDA in its role as the regulatory agency that makes decisions regarding drug safety and efficacy.

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at www.endo-society.org.

AACE is the world’s largest professional medical organization of clinical endocrinologists with more than 6,500 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace. 

id=”nav_links”>

PARIS–(Marketwire – September 23, 2010) – First half-year Financial Information as of June30, 2010

IFRS – Regulated information – Audited

Cegedim: Half-year net profit up 15.6% to ?19.9 million

First half 2010 marked by a strong dynamic commercial performance

Paris, September 23, 2010 – Cegedim, a global technology and services company specializing in the healthcare field, announces consolidated net profit of ?19.9 million for the first half of 2010, up 15.6% over the year-earlier period.

The first half was marked by numerous commercial successes, proving that Cegedim’s range of products and services is well suited to market demand, and that its recent acquisitions hold great promise.

– Simplified income statement

+-------------------------+---------+-------+-------+---------+---------+
|                         |  H1 2010|       |       |  H1 2009|         |
+-------------------------+---------+-------+-------+---------+---------+
|?M                       |        %|       |     ?M|        %|         |
+-------------------------+---------+-------+-------+---------+---------+
|Revenues                 |    448.8|       |  433.9|         |    +3.4%|
+-------------------------+---------+-------+-------+---------+---------+
|EBITDA from ordinary     |     84.1|       |   88.3|         |    -4.7%|
|activities               |         |       |       |         |         |
+-------------------------+---------+-------+-------+---------+---------+
|Depreciation             |    -33.5|       |  -34.2|         |    -2.0%|
+-------------------------+---------+-------+-------+---------+---------+
|Operating profit from    |     50.6|  11.3%|   54.1|    12.5%|    -6.4%|
|ordinary activities      |         |       |       |         |         |
+-------------------------+---------+-------+-------+---------+---------+
|Other exceptional        |     -5.4|       |   -4.7|         |   +17.0%|
|operating revenues /     |         |       |       |         |         |
|expenses                 |         |       |       |         |         |
+-------------------------+---------+-------+-------+---------+---------+
|Operating profit         |     45.2|  10.1%|   49.4|    11.4%|    -8.6%|
+-------------------------+---------+-------+-------+---------+---------+
|Net cost of financial    |    -21.6|       |  -29.8|         |   -27.6%|
|debt                     |         |       |       |         |         |
+-------------------------+---------+-------+-------+---------+---------+
|Tax expenses             |     -4.1|       |   -2.7|         |  +49.1% |
+-------------------------+---------+-------+-------+---------+---------+
|Share of earnings of     |      0.4|       |    0.4|         |     n s |
|equity-accounted         |         |       |       |         |         |
|affiliates               |         |       |       |         |         |
+-------------------------+---------+-------+-------+---------+---------+
|Consolidated net profit  |     19.9|       |   17.2|         |   +15.6%|
+-------------------------+---------+-------+-------+---------+---------+
|Group share of net profit|     19.8|       |   17.2|         |   +15.2%|
+-------------------------+---------+-------+-------+---------+---------+

Consolidated H1 2010 revenues amounted to ?448.8 million, up 0.4% like for like* and 3.4% on a reported basis. As expected, second-quarter growth of 3.8% like for like* and 8.0% on a reported basis offset the first-quarter decline.

The fact that every Group sector made a positive contribution to revenue growth in the second quarter, both like for like* and on a reported basis, is proof of Cegedim’s dynamic sales performance.

Operating profit from ordinary activities came to ?50.6 million, down 6.4% compared with the first half of 2009. This dip is attributable to an increase in personnel costs, which rose 6.2% due to delays implementing certain large-scale CRM projects.

Thus, margin decreased from 12.5% to 11.3%, despite a fine improvement in Healthcare Professionals and Insurance and services sector margins.

Consolidated net profit rose 15.6% compared with a year earlier to ?19.9 million. The biggest contribution to the increase came from lower interest charges on debt, which fell from ?21.4 million to ?10.6 million due to a drop in the average level of outstanding financial debt.

Consolidated net profit attributable to the Group amounted to ?19.8 million, a 15.2% increase over the first half of 2009. Earnings per share amounted to ?1.4, against ?1.8 last year. The increase of the number of shares following the ?180.5 million capital issue of December 2009 explains the drop in EPS.

Sector business trends

– CRM and strategic data

In the first half of 2010, sector revenues rose 3.5% on a reported basis to ?249.1 million. Currency effects and acquisitions helped boost revenues by 1.9% and 2.9% respectively over the first half. Like-for-like revenues fell slightly, by 1.4%. As expected, the 4.8% rise in Q2 revenues helped offset the drop in Q1 caused by delays in executing certain large-scale projects.

One impact of these delays was an increase in personnel costs, which hurt the sector’s operating margin. The sector’s operating profit from ordinary activities was ?18.3 million, down ?6.0 million compared with H1 2009. As a result, operating margin from ordinary activities was 7.3%, versus 10.1% a year earlier.

Second-quarter revenues testify to the sector’s substantial sales momentum, successful geographic expansion of new services, and the beneficial impact of launching new Mobile Intelligence offerings – particularly the SaaS version – with both current and new clients.

Able to integrate SK&A both operationally and commercially in just six months, Cegedim is now fully profiting from the successful strengthening of its OneKey offering in the USA.

These performances lend credence to the Group’s strategic choices: a global presence as a result of the Dendrite acquisition, particularly in rapidly growing markets such as emerging countries; expanding platforms (iPad® and iPhone®, BlackBerry®, etc.); a richer compliance offering in Europe; bringing Dendrite’s business model in line with that of Cegedim (services vs. licenses); and continuing to make substantial investments in R&D to support new products.

The strategic data activity posted a clear rebound in its revenues and profitability in the second quarter. The Group expects this trend to continue in the months ahead.

– Healthcare professionals

Sector first-half 2010 revenues were ?138.7 million, up 0.8% on a reported basis and stable on a like-for-like* basis. Growth of 1.3% in the second quarter offset the slight first-quarter decline, as expected.

Currency effects and acquisitions boosted first-half revenues by 0.5% and 0.4% respectively.

Operating profit from ordinary activities rose 4.2% to ?23.8 million, reflecting a sizeable 60bp increase in the margin to 17.2%. This result is especially remarkable considering that the sector margin was hurt by the wait-and-see attitude of UK physicians and the expected drop in Cegelease’s margin.

The Group continues to generate impressive performances in France, Spain and Italy. In the UK, Cegedim is convinced that it is in a position to profit from new opportunities arising from a reorganization of the UK healthcare system over the coming years.

Lastly, we note that the RMI (paramedic software) and RNP activities (promotional information for pharmacists) continue to turn in very fine performances in terms of revenues and profitability.

After the close of the first-half financial statements, Cegedim’s acquired Pulse, a US company specializing in electronic healthcare records (EHR) management. In the second half, this move will propel the Cegedim Healthcare Software division onto the global stage, positioning the division to capitalize on the considerable new opportunities in this market. For more information on the deal, please see the “Important post-closing transactions and events” section on page 5.

– Insurance and services

Sector revenues rose 9.9% on both a like-for-like* and a reported basis to ?61 million. Insurance and services activities continued to grow by nearly 6% like for like* following an exceptional first quarter.

As expected, operating margin on ordinary activities rose substantially, up 150bp from 12.5% to 14.0%. Operating profit from ordinary activities amounted to ?8.5 million, a 23% increase over the same period in 2009.

These excellent performances are proof that Cegedim’s range of software (Activ’Infinite) and services (various data flow management platforms) is well suited to a rapidly evolving health insurance sector, in which differentiation and productivity gains are crucial.

It is also worth noting the robust trend in the sales of Cegedim SRH, which specializes in the services associated with outsourcing payroll and HR management. Its revenues rose by more than 12% in the first half of 2010, and its profitability improved.

Financial resources

At June 30, 2010, Cegedim’s consolidated total balance sheet amounted to ?1,535 billion, a 15.6% jump over the year-earlier period.

The Group has a robust balance sheet position, with share capital representing 37% of total asset, a 20% increase.

Acquisition goodwill was ?713 million, compared with ?613 million at the end of 2009. This represents 46% of the total balance sheet, which is the same level as six months prior. These trends are attributable chiefly to currency exchange rate and acquisitions.

Cash and equivalents exceed short-term financial debt (less than 1 year).

Netfinancial debt amount to ?443 million compared with ?395 million six months earlier. As expected this increase is due to the use of Cegedim credit revolver facility in order to finance ac quisitions and to the negative evolution of the dollar against the euro.

After the net cost of financial debt and taxes, cash flow was ?51.4 million, on a par with that of the first half of 2009. Gearing level remains unchanged at 0.9 against 0.8 six months earlier.

Working capital requirement increased by ?6.6 million, mainly due to the change in customer receivables. These trends reflect seasonal effects on the Group’s working capital requirement.

At the end of June 2010, the Group complied with all its bank covenants.

First-half highlights

On January 7, 2010, the Group acquired US company SK&A Information Services, Inc., a top-notch supplier of healthcare data. The acquisition strengthens Cegedim’s OneKey offering in the US. Created 26 years ago, SK&A has built and maintains a database with targeted information on more than 2 million healthcare professionals, including more than 800,000 prescribing physicians. This is the only database of US prescribing physicians and other healthcare professionals for which every single email address has been verified by phone contact. The acquired businesses generate full-year revenues of roughly $15 million. Its operational and commercial integration, which was completed in less than 6 months, was a complete success.

On June 3, 2010, Cegedim finalized the acquisition of Swiss CRM and direct marketing businesses from IMS Health to complement and strengthen its existing Swiss offerings. The CRM and Direct Marketing Direct business unit of IMS Health GmbH has been targeting the life science industry in Switzerland for more than a decade and is recognized for its quality and reliability by more than 500 users and 30 companies. The acquired businesses will contribute to the Group’s consolidated result from Q2 2010. Cegedim expects the acquired company to contribute annual revenues in the region of ?2 million.

Moreover, the Group announced on June 18, 2010 the acquisition of French company Hosta, a specialist in third-party management in which it has held a minority stake since 2004. Managing 400,000 beneficiaries and boasting extensive experience in third-party management of health and personal protection insurance policies, Hosta is among France’s leading third-party management companies. This acquisition expands Cegedim Group’s portfolio of solutions dedicated to all of its clients in the insurance sector. The acquired businesses represent annual revenues of approximately ?11 million.

These three deals were financed by internal financing and will not prevent the Group from respecting its debt covenants. Under the agreements signed by the parties, all other terms of the transactions are confidential.

Significant post-closing transactions and events

– Extension of the average maturity of the debt

As part of its policy of diversifying and extending the average maturity of its debt, Cegedim (BB+ S&P), completed on July 27 issuance of a ?300 million bond maturing in 2015, with a fixed annual coupon of 7.00% payable every six months. The strong demand generated by the operation, finalized in just half a day, the quality of the interested parties, and geographic diversity of the investors – of which 70% were located outside of France – enabled Cegedim to raise the ?300 million under favorable conditions. At the same time, the debt issue demonstrates Cegedim’s ability to tap financial markets.

– External growth

On July 27 Cegedim finalized the acquisition of Pulse Systems, Inc., a leading US healthcare software and services supplier. The move gives Cegedim access to the US market for the computerization of healthcare professionals at a very critical time for the Electronic Health Records (EHR) and Practice Management (PM) software markets.

Founded in 1997, Pulse Systems has developed an extremely sophisticated and scalable ambulatory healthcare IT solution – Pulse Patient Relationship Management. This solution includes EHR, PM, e-Prescribing, Revenue Cycle Management services, etc. The company is based in Wichita and has more than 100 employees. Pulse is profitable and will likely continue to grow in a rapidly expanding sector: it expects to increase its revenues more than four-fold by 2014.

Building on the Target Software acquisition in 2005, the Dendrite acquisition in 2007 and the SK&A acquisition earlier this year, this new addition in the US is squarely in line with the Group’s global strategy. It will enable the Group to leverage its complementary activities in North America and transform its European Cegedim Healthcare Software division into a global player by utilizing the Pulse solutions to expand its presence in the US market.

Cegedim finalized the acquisition of Deskom a leading French B-to-B invoice dematerialization company, on September 6th. The deal is an opportunity for Cegedim EDI, its professional electronic data management department, to build on its leadership in the field.

The Deskom acquisition allows Cegedim EDI, the healthcare data exchange leader, to move ahead with its strategy of opening its services to all business sectors and becoming Europe’s top electronic invoicing network, able to handle any request regardless of invoice volumes, project complexity, or the number of countries involved.

These activities represent annual revenues of around ?4 million and will be part of the consolidation scope of Cegedim Group for H2 2010.

These two deals were financed by internal financing. Under the agreements signed by the parties, all other terms of the transactions are confidential.

– New trademark strategy and visual identity for the Group

In order to strengthen its image, Cegedim Management decided to simplify the brand’s visual identity for the Group and its main healthcare Business Units. Each Business Unit’s logo and name will reflect a key description of its overall activity. Therefore, Cegedim Dendrite has been renamed Cegedim Relationship Management.

This change is inspired by the Group’s desire to present its customers with a more coherent, unified image of all of its businesses and to succinctly convey its commitment to providing them with the most advanced products and services in the industry. It is also a way of expressing the successful integration of Dendrite, as the new visual identity will incorporate some graphic elements from its logo.

These changes will take place gradually starting on September 24, 2010. An analysis of the possible accounting consequences of canceling the Dendrite trademark are still under way.

As part of its new brand strategy and to simplify and modernize this window on the Group, Cegedim will launch its new corporate website: www.cegedim.com This new, redesigned portal does more to emphasize the Group’s various activities and gives users direct access to the sites of its Business Units, while incorporating traditional sections on Recruitment, Press and Finance.

2010 outlook

Acquisitions made during the first half-year, as well as the post-closing acquisitions of Pulse and Deskom, are in line with the external growth policy the Group presented at the time of the December 2009 capital increase. These acquisitions did not prevent the Group from meeting all of its covenants. We recall that the sole purpose of the bond issue for ?300 million on July 27, 2010, was to refinance existing bank debt.

Given its adaptability, good regional mix and business mix of revenues, commercial momentum and half-year performances, the Group confirms its goal to consolidate leadership in the global healthcare market with revenue growth of approximately 5% for 2010

Based on its half-year results, the Group is no longer aiming for margin improvement for 2010.

Financial calendar

+-------------------------+--------------------+--------------------+
|The Group will hold a    |                    |                    |
|conference call this     |                    |                    |
|evening (September 23) at|                    |                    |
|6:15 pm in French and    |                    |                    |
|7:00 pm in English at the|                    |                    |
|following numbers (Paris |                    |                    |
|time):                   |                    |                    |
+-------------------------+--------------------+--------------------+
|                         |· From France: 01 72|Access code:        |
|                         |30 02 03            |13648531            |
+-------------------------+--------------------+--------------------+
|                         |· From UK: 1616 018 |#                   |
|                         |915                 |                    |
+-------------------------+--------------------+--------------------+
|                         |· From the US: 703  |                    |
|                         |62 19 122           |                    |
+-------------------------+--------------------+--------------------+
+-------------------------+--------------------+--------------------+

September 24, 2010

– SFAF Meeting – 24 rue de Penthièvre 75008 Paris (at 10:00am)

– Half-year Financial Report (after the stock market closes)

From September 27 to October 15, 2010

– Roadshow in Europe

From October 4 to October 8, 2010

– Roadshow in the US

November 15, 2010

– Q3 revenues announcement (after the stock market closes)

Additional information

The Board of Directors and the Auditors met on September 23, 2010, to approve 2010 Half-year consolidated financial statements. Audit procedures have been performed and the 2010 Half-year statutory auditors’ report on the consolidated financial statements is forthcoming.

The financial information presented in this press release comes from Cegedim half year consolidated financial statements and is fully available on the 2010 Half-year Financial Report at www.cegedim.fr/finance as of September 24, 2010.

A presentation of Cegedim 2010 Half-year results is also available on the Website.

Appendices

– Revenues by sector and by quarter#:

# Figures rounded to the nearest unit.

Year 2010

+-------------------------+---------+---------+----+----+---------+
|? thousands              |    Q1   |    Q2   |  Q3|  Q4|   Total |
+-------------------------+---------+---------+----+----+---------+
|CRM and strategic data   |  111,532|  137,575|    |    |  249,107|
+-------------------------+---------+---------+----+----+---------+
| Healthcare professionals|   64,461|   74,278|    |    |  138,739|
+-------------------------+---------+---------+----+----+---------+
|Insurance and services   |   29,627|   31,364|    |    |   60,991|
+-------------------------+---------+---------+----+----+---------+
|Group                    |  205,620|  243,217|    |    |  448,837|
+-------------------------+---------+---------+----+----+---------+
+-------------------------+---------+---------+----+----+---------+

Year 2009 pro-forma

For information, Revenues at June 30, 2009 were restated between sectors for an amount of ?4.4 million. In order to continue streamlining the Group’s structure, certain activities of the Healthcare professionals and Insurance and services sectors have been linked to entities of the CRM and strategic data sector. Pro-forma revenue is mentioned below.

+-------------------------+---------+---------+---------+---------+---------+
|? thousands              |    Q1   |    Q2   |    Q3   |    Q4   |   Total |
+-------------------------+---------+---------+---------+---------+---------+
|CRM and strategic data   |  117,523|  123,223|  117,178|  140,361|  498,285|
+-------------------------+---------+---------+---------+---------+---------+
| Healthcare professionals|   65,247|   72,411|   58,779|   67,817|  264,254|
+-------------------------+---------+---------+---------+---------+---------+
|Insurance and services   |   25,892|   29,609|   22,062|   33,970|  111,533|
+-------------------------+---------+---------+---------+---------+---------+
|Group                    |  208,662|  225,245|  198,017|  242,148|  874,072|
+-------------------------+---------+---------+---------+---------+---------+
+-------------------------+---------+---------+---------+---------+---------+

– By sector of activity and currency, the distribution of revenues for the first half-year of 2010 is as follows:

+-------------------------+------+-----+-----+--------+
|                         |  Euro|  USD|  GBP|  Others|
+-------------------------+------+-----+-----+--------+
|CRM and strategic data   |   51%|  23%|   4%|     22%|
+-------------------------+------+-----+-----+--------+
| Healthcare professionals|   80%|    -|  20%|       -|
+-------------------------+------+-----+-----+--------+
|Insurance and services   |   99%|    -|    -|      1%|
+-------------------------+------+-----+-----+--------+
|Group                    |   66%|  13%|   9%|     12%|
+-------------------------+------+-----+-----+--------+
+-------------------------+------+-----+-----+--------+

– By sector of activity and geographic zone, the distribution of revenues for the first half-year of 2010 is as follows:

+-------------------------+--------+------------------+---------------+
|                         |  France|  Europe ex France|  North America|
+-------------------------+--------+------------------+---------------+
|CRM and strategic data   |     31%|               33%|            24%|
+-------------------------+--------+------------------+---------------+
| Healthcare professionals|     77%|               23%|              -|
+-------------------------+--------+------------------+---------------+
|Insurance and services   |     99%|                 -|              -|
+-------------------------+--------+------------------+---------------+
|Group                    |     55%|               26%|            13%|
+-------------------------+--------+------------------+---------------+
+-------------------------+--------+------------------+---------------+

+-------------------------+-------------------+
|                         |  Rest of the world|
+-------------------------+-------------------+
|CRM and strategic data   |                12%|
+-------------------------+-------------------+
| Healthcare professionals|                  -|
+-------------------------+-------------------+
|Insurance and services   |                 1%|
+-------------------------+-------------------+
|Group                    |                 7%|
+-------------------------+-------------------+
+-------------------------+-------------------+

– Consolidated first-half financial statements

Assets

+-------------------------+------------+------------+
|? thousands              |  06/30/2010|  06/30/2009|
+-------------------------+------------+------------+
|Goodwill on acquisition  |     713,179|     613,342|
+-------------------------+------------+------------+
|Development costs        |      31,057|      57,644|
+-------------------------+------------+------------+
|Trademarks, patents      |     135,868|     104,810|
+-------------------------+------------+------------+
|Other intangible fixed   |     106,145|      63,192|
|assets                   |            |            |
+-------------------------+------------+------------+
|Intangible fixed assets  |     273,070|     225,646|
+-------------------------+------------+------------+
|Property                 |         446|         417|
+-------------------------+------------+------------+
|Buildings                |       6,168|       6,225|
+-------------------------+------------+------------+
|Plant, machinery and     |      24,940|      24,377|
|equipment                |            |            |
+-------------------------+------------+------------+
|Other tangible fixed     |      13,866|      13,969|
|assets                   |            |            |
+-------------------------+------------+------------+
|Construction work in     |          35|         234|
|progress                 |            |            |
+-------------------------+------------+------------+
|Tangible fixed assets    |      45,456|      45,221|
+-------------------------+------------+------------+
|Equity investments       |         295|         302|
+-------------------------+------------+------------+
|Loans                    |         555|         551|
+-------------------------+------------+------------+
|Other fixed financial    |       9,103|       8,030|
|assets                   |            |            |
+-------------------------+------------+------------+
|Fixed financial assets ? |       9,953|       8,883|
|excluding shares of      |            |            |
|equity-accounted         |            |            |
|affiliates               |            |            |
+-------------------------+------------+------------+
|Shares of                |       6,811|       7,173|
|equity-accounted         |            |            |
|affiliates               |            |            |
+-------------------------+------------+------------+
|Government ? Deferred tax|      42,476|      33,350|
+-------------------------+------------+------------+
|Accounts receivable:     |      16,056|      15,282|
|long-term portion        |            |            |
+-------------------------+------------+------------+
|Other receivables:       |       2,064|         983|
|long-term portion        |            |            |
+-------------------------+------------+------------+
|Non-current assets       |   1,109,064|     949,881|
+-------------------------+------------+------------+
|Services in progress     |         188|         200|
+-------------------------+------------+------------+
|Goods                    |      11,005|      10,956|
+-------------------------+------------+------------+
|Advances and deposits    |       1,882|       1,172|
|received on orders       |            |            |
+-------------------------+------------+------------+
|Accounts receivable:     |     226,488|     210,502|
|short-term portion       |            |            |
+-------------------------+------------+------------+
|Unpaid, called-up capital|           -|           -|
+-------------------------+------------+------------+
|Other receivables:       |      20,533|      18,413|
|short-term portion       |            |            |
+-------------------------+------------+------------+
|Cash equivalents         |       1,159|      30,630|
+-------------------------+------------+------------+
|Cash                     |     141,814|      90,739|
+-------------------------+------------+------------+
|Prepaid expenses         |      22,936|      15,847|
+-------------------------+------------+------------+
|Current assets           |     426,006|     378,461|
+-------------------------+------------+------------+
|Total assets             |   1,535,070|   1,328,341|
+-------------------------+------------+------------+

Liabilities

+-------------------------+------------+------------+
|? thousands              |  06/30/2010|  06/30/2009|
+-------------------------+------------+------------+
|Share capital            |      13,337|      13,337|
+-------------------------+------------+------------+
|Issue premium            |     185,562|     185,562|
+-------------------------+------------+------------+
|Group reserves           |     294,967|     249,732|
+-------------------------+------------+------------+
|Group translation        |        -238|        -238|
|reserves                 |            |            |
+-------------------------+------------+------------+
|Group translation        |      46,317|     -37,844|
|gains/losses             |            |            |
+-------------------------+------------+------------+
|Group earnings           |      19,849|      54,719|
+-------------------------+------------+------------+
|Investment subsidies     |           -|           -|
+-------------------------+------------+------------+
|Regulated provisions     |           -|           -|
+-------------------------+------------+------------+
|Shareholders? equity,    |     559,794|     465,267|
|Group share              |            |            |
+-------------------------+------------+------------+
|Minority interests       |         383|         609|
|(reserves)               |            |            |
+-------------------------+------------+------------+
|Minority interests       |          72|         114|
|(earnings)               |            |            |
+-------------------------+------------+------------+
|Minority interests       |         455|         724|
+-------------------------+------------+------------+
|Shareholders? equity     |     560,249|     465,991|
+-------------------------+------------+------------+
|Long-term financial      |     453,067|     391,408|
|liabilities              |            |            |
+-------------------------+------------+------------+
|Long-term financial      |      10,707|      16,517|
|instruments              |            |            |
+-------------------------+------------+------------+
|Deferred tax liabilities |      60,298|      51,394|
+-------------------------+------------+------------+
|Non-current provisions   |      28,534|      21,517|
+-------------------------+------------+------------+
|Other non-current        |      12,396|       9,550|
|liabilities              |            |            |
+-------------------------+------------+------------+
|Non-current liabilities  |     565,002|     490,386|
+-------------------------+------------+------------+
|Short-term financial     |     142,671|     133,621|
|liabilities              |            |            |
+-------------------------+------------+------------+
|Short -term financial    |           -|           -|
|instruments              |            |            |
+-------------------------+------------+------------+
|Accounts payable and     |      71,813|      73,604|
|related accounts         |            |            |
+-------------------------+------------+------------+
|Tax and social           |     119,088|     113,705|
|liabilities              |            |            |
+-------------------------+------------+------------+
|Provisions               |       6,116|       7,133|
+-------------------------+------------+------------+
|Other current liabilities|      70,131|      43,902|
+-------------------------+------------+------------+
|Current liabilities      |     409,819|     371,965|
+-------------------------+------------+------------+
|Total liabilities        |   1,535,070|   1,328,341|
+-------------------------+------------+------------+

– Income statement

+-------------------------+------------+------------+
|? thousands              |  06/30/2010|  06/30/2009|
+-------------------------+------------+------------+
|Revenues                 |     448,837|     433,906|
+-------------------------+------------+------------+
|Other income from        |           -|           -|
|business activities      |            |            |
+-------------------------+------------+------------+
|Capitalized production   |      15,186|      16,616|
+-------------------------+------------+------------+
|Purchased consumed       |     -48,637|     -47,729|
+-------------------------+------------+------------+
|External expenses        |    -110,205|    -106,409|
+-------------------------+------------+------------+
|Taxes                    |      -7,069|      -6,503|
+-------------------------+------------+------------+
|Payroll costs            |    -213,954|    -201,391|
+-------------------------+------------+------------+
|Depreciation expenses    |     -33,494|     -34,179|
+-------------------------+------------+------------+
|Provision expenses and   |         -69|         391|
|write-backs              |            |            |
+-------------------------+------------+------------+
|Change in inventories of |         -20|         -63|
|in-progress and finished |            |            |
|products                 |            |            |
+-------------------------+------------+------------+
|Other operating income   |          49|        -560|
|and expenses             |            |            |
+-------------------------+------------+------------+
|Operating profit from    |      50,624|      54,079|
|ordinary activities      |            |            |
+-------------------------+------------+------------+
|Other non-current        |      -5,448|      -4,657|
|operating income and     |            |            |
|expenses                 |            |            |
+-------------------------+------------+------------+
|Operating profit         |      45,175|      49,422|
+-------------------------+------------+------------+
|Income from cash and cash|         564|         829|
|equivalents              |            |            |
+-------------------------+------------+------------+
|Gross cost of financial  |     -12,283|     -20,304|
|debt                     |            |            |
+-------------------------+------------+------------+
|Other financial income   |      -9,866|     -10,349|
|and expenses             |            |            |
+-------------------------+------------+------------+
|Net cost of financial    |     -21,585|     -29,824|
|debt                     |            |            |
+-------------------------+------------+------------+
|Income taxes             |     -16,134|      -3,005|
+-------------------------+------------+------------+
|Deferred income taxes    |      12,069|         279|
+-------------------------+------------+------------+
|Tax expenses             |      -4,065|      -2,726|
+-------------------------+------------+------------+
|Share of earnings of     |         396|         368|
|equity-accounted         |            |            |
|affiliates               |            |            |
+-------------------------+------------+------------+
|Consolidated net profit  |      19,921|      17,240|
+-------------------------+------------+------------+
|Group share (A)          |      19,849|      17,237|
+-------------------------+------------+------------+
|Minority interests       |          72|           3|
+-------------------------+------------+------------+
|Average number of shares |  13,963,775|   9,331,449|
|excl. Treasury stocks (B)|            |            |
+-------------------------+------------+------------+
|Earnings per share -     |         1.4|         1.8|
|euros (A/B)              |            |            |
+-------------------------+------------+------------+
|Dilutive instruments     |           -|           -|
+-------------------------+------------+------------+
|Diluted earnings per     |         1.4|         1.8|
|share - euros            |            |            |
+-------------------------+------------+------------+

– Cash flow statement

+-------------------------+------------+------------+
|? thousands              |  06/30/2010|  06/30/2009|
+-------------------------+------------+------------+
|Consolidated net profit  |      19,921|      17,240|
+-------------------------+------------+------------+
|Share of earnings of     |        -396|        -368|
|equity-accounted         |            |            |
|affiliates               |            |            |
+-------------------------+------------+------------+
|Depreciation and         |      31,885|      34,411|
|amortization expense     |            |            |
+-------------------------+------------+------------+
|Capital gain or losses on|         -33|         275|
|disposals                |            |            |
+-------------------------+------------+------------+
|Cash flow after net cost |      51,377|      51,558|
|of financial debt and    |            |            |
|taxes                    |            |            |
+-------------------------+------------+------------+
|Net cost of financial    |      21,585|      29,824|
|debt                     |            |            |
+-------------------------+------------+------------+
|Tax expenses             |       4,065|       2,726|
+-------------------------+------------+------------+
|Cash flow before net cost|      77,027|      84,108|
|of financial debt and    |            |            |
|taxes                    |            |            |
+-------------------------+------------+------------+
|Tax paid                 |      -9,368|         245|
+-------------------------+------------+------------+
|Plus: change in operating|     -17,759|     -11,179|
|working capital          |            |            |
|requirement              |            |            |
+-------------------------+------------+------------+
|Net cash from operations |      49,900|      73,174|
|(A)                      |            |            |
+-------------------------+------------+------------+
|Acquisitions of          |     -18,160|     -20,044|
|intangible fixed assets  |            |            |
+-------------------------+------------+------------+
|Acquisitions of tangible |     -13,045|     -12,098|
|fixed assets             |            |            |
+-------------------------+------------+------------+
|Acquisitions of financial|           -|      -1,454|
|assets                   |            |            |
+-------------------------+------------+------------+
|Disposals of tangible and|       2,074|       2,263|
|intangible fixed assets  |            |            |
+-------------------------+------------+------------+
|Disposals of financial   |         124|         363|
|assets                   |            |            |
+-------------------------+------------+------------+
|Impact of changes in     |     -25,680|      -2,691|
|consolidation scope      |            |            |
+-------------------------+------------+------------+
|Dividends from equity    |           -|           -|
|accounted affiliates     |            |            |
+-------------------------+------------+------------+
|Net cash from investment |     -54,687|     -33,661|
|operations (B)           |            |            |
+-------------------------+------------+------------+
|Dividends paid to parent |           -|           -|
|company shareholders     |            |            |
+-------------------------+------------+------------+
|Dividends paid to the    |           -|           -|
|minority interests of    |            |            |
|consolidated companies   |            |            |
+-------------------------+------------+------------+
|Increase in cash capital |           -|           -|
+-------------------------+------------+------------+
|Debt issued              |      61,611|      62,240|
+-------------------------+------------+------------+
|Debt reimbursements      |     -57,587|     -86,091|
+-------------------------+------------+------------+
|Interest paid on debts   |     -10,606|     -21,435|
+-------------------------+------------+------------+
|Other financial income   |      -8,073|      -2,675|
|and expenses             |            |            |
+-------------------------+------------+------------+
|Net cash from financing  |     -14,655|     -47,961|
|operations ©           |            |            |
+-------------------------+------------+------------+
|Change in cash (A+B+C)   |     -19,442|      -8,448|
+-------------------------+------------+------------+
|Opening cash position    |     102,338|      70,254|
+-------------------------+------------+------------+
|Closing cash position    |      89,379|      61,539|
+-------------------------+------------+------------+
|Foreign exchange gains or|      -6,483|         267|
|losses                   |            |            |
+-------------------------+------------+------------+

*at constant scope and exchange rates

About Cegedim: Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,600 people in more than 80 countries and generated revenue of ?874 million in 2009. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.com

Contacts:

+--+--------------------+--------------------+--------------------+--+
|  |     Aude BALLEYDIER|Jan Eryk UMIASTOWSKI|Guillaume DE        |  |
|  |                    |                    |CHAMISSO            |  |
+--+--------------------+--------------------+--------------------+--+
|  |             Cegedim|             Cegedim|Presse & Papiers    |  |
|  |                    |                    |Agency              |  |
+--+--------------------+--------------------+--------------------+--+
|  |     Media Relations|Chief investment    |       Press Officer|  |
|  |                    |Officer Investor    |                    |  |
|  |                    |Relations           |                    |  |
+--+--------------------+--------------------+--------------------+--+
|  |                    |Tel.: +33 (0)1 49 09|                    |  |
|  |                    |33 36               |                    |  |
+--+--------------------+--------------------+--------------------+--+
|  |Tel.: +33 (0)1 49 09|investor.relations@c|Tel.: +33 (0)1 77 35|  |
|  |68 81               |egedim.fr           |60 99               |  |
+--+--------------------+--------------------+--------------------+--+
|  |aude.balleydier@cege|                    |guilaume.dechamisso@|  |
|  |dim.fr              |                    |pressepapiers.fr    |  |
+--+--------------------+--------------------+--------------------+--+
+--+--------------------+--------------------+--------------------+--+

This information is provided by HUGIN

MINNEAPOLIS, MN–(Marketwire – September 23, 2010) –  Indigo Identityware, a growing leader in the Identity & Access Management industry, has partnered with Netgain to market and deploy its software-only solution that offers Behavioral Strong Authentication, single sign-on and session management for the extended enterprise. Indigo’s secure identity management solutions, paired with Netgain’s data security and delivery, meet clinicians’ desire for increased productivity and simplicity. 

In the ever-increasing security conscious environment, healthcare providers are required to use multiple complex passwords when accessing patient records. With Indigo’s solution, it eliminates the cumbersome password process while maintaining security, allowing the doctor more time to focus on the patient.

“Our clients trust us to provide an all-encompassing solution that combines HIPAA-level security with ease of use, and we found that with Indigo. By utilizing their unique Behavioral Strong Authentication and Single Sign-on solution, providers are more productive and the patient’s experience is enhanced because doctors can focus on the patient instead of worrying about complex or forgotten passwords,” said Matt Riley, Netgain’s COO.

“We’re excited to work with an organization like Netgain, whose mission in healthcare IT so closely aligns with ours,” said John Woodward, COO and President of Healthcare for Indigo Identityware. “Our services are complementary to Netgain’s, and together we provide a complete solution that addresses a major issue for all healthcare organizations.”

About Netgain
Netgain, a privately held provider of healthcare information technology solutions, relieves the day-to-day burden of information technology operations for healthcare organizations. Netgain provides application hosting and infrastructure support with extensive technical expertise in securing sensitive data by deploying a rare combination of process excellence and personal service. 

About Indigo
Indigo Identityware, a leader in the identity and access management industry, distinguishes itself by offering the first and only Behavioral Strong Authentication and Single Sign-on solution for the extended enterprise. Indigo’s flexible design supports multiple strong authentication methods, including next generation biometrics, providing users with secure and fast access to information. It increases workflow productivity while helping customers ensure regulatory compliance. The software-only solution is cost-effective and deploys quickly for organizations of any size.  

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Sept. 23, 2010) – Reduced wait times and better access to hospital services are among the benefits patients in BC’s health care system could expect with the implementation of Patient Focused Funding (PFF). In this model, patients are seen as a benefit to hospitals instead of a cost. Hospitals would be paid for every patient they treat providing the impetus to see everyone in a timely manner and increase the volume of services provided to patients. The measures used to determine success of PFF programs must be evidence-based, risk-adjusted, and developed in collaboration with patient representatives.

Recently, there have been various funding models discussed by government and other stakeholders in the quest to contain health care costs. Patient Focused Funding in this case is defined as any method of compensating providers – which can include physicians, nurses, and hospitals – that uses financial incentives to improve the appropriateness, quality, and efficiency of care for patients. The BC Medical Association has released its policy paper Valuing Quality: Patient-Focused funding in British Columbia, which offers ten recommendations on the structure, implementation and evaluation of PFF including:

• Any PFF program must be designed to support and improve the timeliness, safety, and health outcomes of patient care within a cost certain environment.
• A multi-stakeholder working group under the BC Health Services Purchasing Organization must be created and should include physicians and other health care providers.
• All PFF programs must be rigorously evaluated for their impact on patient care, access and costs.

“Our research has shown that PFF models need to be flexible and phased in to any situation in which they could be applied,” said Dr. David Attwell, Chair of the Working Group that developed the paper. “Implementation of a successful PFF program requires system-wide collaboration, commitment and leadership to achieve the highest level of quality for patients, for those who work in the health care system, and for government who pays for it.”

The BC government has recently announced its investment of $250 million, plus another $24.3 million, to launch and further develop its PFF model. Although the BC Medical Association supports many of government’s PFF initiatives, we also believe that patient safety and quality of care must be included as key measurement criteria. As well, more work needs to be done to ensure everyone involved in PFF from hospitals to health care providers to government share the same understanding of how PFF models function.

The policy paper can be found on the BCMA website at www.bcma.org.

PLYMOUTH, MN–(Marketwire – September 23, 2010) –  Hearing loss is now the third most common chronic, but manageable, health condition in the United States, after arthritis and high blood pressure, according to the Hearing Loss Association of America (HLAA). Yet, fewer than half of those with hearing loss who could benefit from hearing aids use them. “During Hearing Aid Awareness Week, October 3 – 10, we want to help everyone understand how important it is to take steps to detect and manage hearing loss early, before it has a chance to impact your quality of life and even your earning potential,” says Rebecca Younk, audiologist for Miracle-Ear.

According to the HLAA, 1 in 10 Americans experiences some type of hearing loss. And yet, fewer than half of those hearing-impaired individuals use any type of hearing aid. Why? One reason may be that hearing loss is so gradual over time, that most people don’t notice a change until it has become really pronounced. Other reasons may include embarrassment. “Even though eyeglasses and contact lenses have now become perfectly socially acceptable, we still have to work hard to ensure that hearing aid wearers are treated with the same respect as eyeglass wearers,” explains Younk.

“The impact that unmanaged hearing loss can have on your life goes way beyond missing a word in a conversation here and there,” emphasizes Younk. “Here are just a few good reasons, beyond simply enhancing your overall quality of life, to consider having a hearing test soon.”

• Hearing loss can starve the auditory centers of the brain of acoustic information, leading to auditory deprivation — and a resulting decrease in speech understanding. Hearing aids can help these auditory centers “stay busy,” to protect against this loss.
• Research available at The Better Hearing Institute (BHI) suggests that patients with unmanaged hearing loss suffer more from depression and social isolation compared to those of similar age who wear hearing aids.
• A study conducted by the BHI also suggests that hearing impaired patients choosing not to wear hearing aids earn less when compared to hearing impaired patients who choose to use hearing aids.

Today’s hearing aids offer discreet, customized hearing solutions, tailored to your lifestyle, age and activities. Miracle-Ear offers a comprehensive hearing assessment that includes a complete hearing health history, ear canal inspection, hearing threshold test and speech discrimination test. If these tests indicate a hearing loss, Miracle-Ear works with the client to determine which solution best meets his or her individual needs.

“Hearing loss is a growing problem in the U.S.,” says Younk, “but only about 13 percent of physicians routinely screen for hearing loss during a physical. You could have hearing loss and not even know it. It’s the people closest to you who may recognize it first. If your friends or family are advising you to have your hearing tested, you should listen to them!”

For more information on Miracle-Ear, please visit http://www.miracle-ear.com/.

About Miracle-Ear
A trusted resource for hearing solutions for over 60 years, Miracle-Ear uses state-of-the-art technology to remove the barriers of hearing loss. The Plymouth, Minn.-based company specializes in customizable hearing solutions that feature discreet, comfortable products designed to meet each individual’s hearing loss needs. Free hearing tests and consultations are available at all of the company’s 1,200 locations across the U.S., many of which are in Sears stores. Franchise opportunities are available for those interested in running their own Miracle-Ear business with the support of a nationwide industry leader. 

For more information, visit www.miracle-ear.com. 

SAN FRANCISCO, CA–(Marketwire – September 23, 2010) –  Medizone International, Inc. (OTCBB: MZEI) (OTCQB: MZEI) announced today the Company has filed a fourth U.S. Provisional patent application involving what it terms, “Advanced Oxidative Sterilization Processes.”

Dr. Michael Shannon, Director of Medical Affairs, explained, “We are now exploring a new development in the field of oxidative chemistry which we believe will have a significant impact on our future technology and the ease with which we can effectively decontaminate hospitals, chronic care facilities, veterinary facilities, hotels, cruise ships, sports facilities and the equipment therein. Our research to date clearly demonstrates that the combination of modest levels of ozone and low concentrations of peroxide, properly delivered at the right temperature and humidity, will reliably eliminate bacterial loads of at least 6 logs (sterilization standard) on a broad range of surface materials, including carpets, for all of the ‘Superbugs’ responsible for Hospital Acquired Infections. This new development, however, further enhances Medizone’s AsepticSure™ technology in a manner not anticipated. In fact, decontamination in the future will very likely be based on unique combinations of what we are calling ‘Advanced Oxidative Sterilization Processes’ which build on the existing technology by using a family of chemical moieties considered to be even more potent than either ozone or peroxide to destroy a broad range of potentially lethal pathogens. Research is now underway at our laboratories in Kingston on a parallel track with our hospital beta testing program to evaluate the merits of a multifactorial decontamination system which appears to further increase the potency of AsepticSure™ while dramatically reducing the exposure time, both of which have major implications for certain applications.”

Medizone’s CEO, Edwin Marshall, added, “With two international patent applications filed in addition to the four U.S. provisional applications now in place, we are taking the steps we believe necessary to fully protect the commercial rights of Medizone International. It is now clear that what began as a technology to decontaminate and sterilize hospital spaces has grown into the foundations of an entirely new sterilization industry. We are developing a family of solutions based on the nuances of specific applications. Given the outcomes of recent meetings with both private industry players and government, it is clear we are not alone in recognizing this concept. As I announced in a recent interview with Don Baillargeon for a segment of his show, ‘MoneyTV,’ to be aired this coming Saturday, we have even filed a patent application addressing the bed bug issue for the cruise ship and hotel industry. We are not making too much of it yet, as the science for that application remains to be completed. However, we are guardedly optimistic that we will be able to provide an effective and affordable solution to that market segment as well, and thus wanted to get the IP protection in place as soon as possible.”

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures with additional variants for sports facilities and food processing applications and, potentially, the hotel and cruise ship industry for bed bug eradication and Norwalk virus.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Click here to see all recent news from this company

TORONTO, ONTARIO–(Marketwire – Sept. 23, 2010) –

Editors Note: A photo for this release will be available via Marketwire on the picture wire of The Canadian Press.

Ornge, a world leader in the field of transport medicine, is proud to introduce the most significant fleet upgrade in the history of aero medical transport in Ontario. The first of the new AgustaWestland AW139 helicopters were unveiled this morning at the Ornge base at the Billy Bishop Toronto City Airport. The new helicopters will transport Ornge’s medical teams who provide services for patients requiring advanced and critical levels of care during transport.

Ornge paramedics and pilots employed by CHL, the operator of Ornge rotor aircraft, will begin transporting patients in the new high-performance medium twin turbine helicopters over the coming months. Ornge purchased ten AW139 aircraft from AgustaWestland, a Finnmeccanica company, in 2008 to replace the older fleet of Sikorsky S76 helicopters currently in use at Ornge bases across the province. 

“As innovators in our field, we are on the cutting edge of both aviation and medicine,” said Dr. Christopher Mazza, Ornge CEO and Emergentologist. “The AW139 medically-equipped aircraft will help us to deliver a modern, high quality, sustainable transport medicine program for Ontario patients today and for generations to come.”

The AW139 is the most technologically advanced rotor wing aircraft in air medical transport today. The fastest helicopter in its class, it is capable of operating in a wide variety of weather conditions – from extreme heat to extreme cold – found across Ontario’s one million square kilometers. Ornge is the first AgustaWestland client in North America to have a full ice protection installed in medically equipped helicopters. The AW139 also has enhanced safety and environmental features.

Giuseppe Orsi, Chief Executive Officer, AgustaWestland said: “We are proud to be part of this new era in transport medicine in Ontario providing the best medium twin helicopter to such a leading operator and to the benefit of the large community they serve. The AW139 will enable Ornge to perform a quantum leap forward in operational capability to successfully accomplish the mission and save lives in the harshest conditions when other models would be confined to the hangar.”

Each helicopter is outfitted with an advanced full medical interior designed and configured by Ornge transport medicine physicians and paramedics in collaboration with Aerolite, a world leader in medical helicopter and fixed-wing aircraft interiors. 

In January 2006, Ornge began coordinating all aspects of the province’s transport medicine system. Since then, Ornge has transported nearly 95,000 patients more than 30 million statute miles – over 1,200 times around the earth — in its rotor and fixed wing aircraft, along with its critical care land units.

ABOUT ORNGE

Ornge is the world’s leading innovator in the emerging field of transport medicine, and operates from a number of bases across the province of Ontario and performs more than 20,000 admissions annually. It coordinates all aspects of Ontario’s aero medical transport system, the new critical care land transport program, paediatric transport program and the authorization of air and land ambulance transfers between hospitals. Ornge is dedicated to the provision of high quality patient care through innovative transport medicine.

ABOUT AGUSTAWESTLAND

AgustaWestland, a Finmeccanica company, is a technology leader in its markets and has an unrivalled range of rotorcraft products designed to satisfy the requirements of commercial and military customers. AgustaWestland has its main operations in Italy, the United Kingdom and the United States of America.

ATLANTIC CITY, NJ–(Marketwire – September 23, 2010) – GetWellNetwork, Inc., today announced that David Wright, the Company’s chief outcomes officer, will address the New Jersey and Delaware chapters of HIMSS on how hospitals can strengthen their position in the “Pay for Performance” provisions of the new health care reform law. The fall regional health information symposium is being held from September 22-24th at the Atlantic City Caesars Hotel and Casino.

Mr. Wright will share with attendees how the “Pay for Performance” model impacts the quality measurements that are being evaluated in the Patient Protection and Affordable Care Act’s Value-Based Purchasing and Accountable Care Organizations programs. “Pay for Performance” programs measure a variety of performance indicators such as clinical processes of care, health outcomes, patient safety, patient experience and satisfaction, and information technology investment and use.

Mr. Wright will also explain how leading hospitals and health systems are using interactive patient care technology to achieve evidence-based outcomes and to improve hospital performance in these areas that directly impact “Pay for Performance” provisions.

Without a clear outcomes plan and technology solution in place, hospitals may see dramatic reductions in their Medicare reimbursements as early as October 2012 with payments made based on 2011-2012 performance(1). Using best practices and practical examples from leading hospitals, Mr. Wright will provide insights that will help hospitals formulate their own plans to become “high performers” in the era of health care reform.

“The regional HIMSS conference provides an opportunity to address the key issues hospitals must consider for implementing initiatives that affect the patient care factors of the Pay for Performance provision,” said David Wright, chief outcomes officer, GetWellNetwork, Inc. “To ensure continuation of maximum reimbursements from the Federal government, all hospitals need to have a core strategy that helps them excel in the new performance measurements that will be used to calculate their effectiveness in patient treatment.”

About GetWellNetwork
GetWellNetwork, Inc. uses the bedside TV to entertain, educate and empower hospital patients and caregivers to be more actively engaged in their care. This patient-centered approach improves both satisfaction and outcomes for patients and hospitals. GetWellNetwork is the leader in interactive patient care solutions and exclusively endorsed by the American Hospital Association. More information about GetWellNetwork can be found at www.GetWellNetwork.com.

(1) More information about CMS’ Value-Based Purchasing Program is available at http://www.cms.gov/AcuteInpatientPPS/downloads/HospitalVBPPlanRTCFINALSUBMITTED2007.pdf and http://www.cms.gov/QualityInitiativesGenInfo/downloads/VBPRoadmap_OEA_1-16_508.pdf

Click here to see all recent news from this company

SOUTH SAN FRANCISCO, CA–(Marketwire – September 23, 2010) – Portola Pharmaceuticals, Inc. today announced the appointment of Jean-Jacques Bienaimé to the company’s board of directors. Mr. Bienaimé currently serves as chief executive officer of BioMarin Pharmaceutical Inc. He is chairman of the board of NeurogesX, Inc., a member of the board of BIO and a member of the advisory board of Bellevue Asset Management’s BioVentures II fund.

“Jean-Jacques Bienaimé is a biotechnology and pharmaceutical industry veteran with more than 25 years of experience,” said William Lis, chief executive officer of Portola. “His experience as a CEO managing and building fully integrated biotechnology companies and his expertise commercializing anti-thrombotic products will be invaluable to Portola as we advance our two lead partnered product candidates, elinogrel and betrixaban, and our pipeline of proprietary products in cardiovascular disease and inflammation through clinical development and into commercialization.”

Mr. Bienaimé joined BioMarin, which develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, in May 2005 as chief executive officer and member of the board of directors. Prior to joining BioMarin, he served as chairman, chief executive officer and president of Genencor, a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics. Before that, he served as chairman, chief executive officer and president of Sangstat Medical Corporation, an immunology-focused biotechnology company that he guided to profitability prior to its acquisition by Genzyme Corporation. Earlier in his career, Mr. Bienaimé held several senior management positions at Rhone-Poulenc Rorer Pharmaceuticals (now sanofi-aventis) culminating in the position of senior vice president of worldwide marketing and business development responsible for, among other things, the launch of Lovenox^® (for the prevention of pulmonary embolism and treatment of unstable angina) in the United States. He also worked at Genentech, Inc. where he was involved in the launch of tissue plasminogen activator (t-PA) for the treatment of heart attacks.

He received an M.B.A. from the Wharton School at the University of Pennsylvania and an undergraduate degree in economics from the École Supérieure de Commerce de Paris.

About Portola Pharmaceuticals, Inc.
Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascular disease and inflammation. The company has global development and commercialization agreements with two of the world’s leading pharmaceutical companies collectively valued at about $1 billion in upfront and milestone payments plus double-digit royalties on future sales. Betrixaban, its oral direct Factor Xa inhibitor, is licensed to Merck & Co., Inc., and elinogrel, its competitive, reversible P2Y₁₂ ADP receptor antagonist, is licensed to Novartis Pharma AG. Both are Phase 2 product candidates that have features to address the global multi-billion dollar hospital, specialty and chronic care anticoagulant and antiplatelet markets, respectively.

Portola’s proprietary pipeline programs are focused on the discovery and development of PRT061103, a thromboxane receptor antagonist, which is targeted to address a significant unmet need as a potential aspirin alternative for patients intolerant to aspirin; PRT064445, a Factor Xa inhibitor antidote to help manage or reverse the bleeding complications in the tens of millions of patients expected to be treated with Factor Xa inhibitors or low-molecular weight heparin worldwide in the next decade; and PRT062607, a novel, oral Syk-specific kinase inhibitor to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. For additional information, visit www.portola.com.

LAUSANNE, SWITZERLAND–(Marketwire – September 23, 2010) –  

• 40 patients enrollment completion
• Positive preliminary results

Symetis SA, a private Swiss company developing new transcatheter aortic valve implantation (TAVI) systems, announced today the completion of patient enrollment in its ACURATE TA™ first-in-man (FIM) clinical study and positive preliminary results. ACURATE TA™ is a self-aligning nitinol stent valve designed for optimal trans-apical delivery, providing the physician with unmatched positioning tolerance and ease of use.

Details of the study
The study — the largest 2nd generation TAVI FIM study ever conducted — was conducted at 5 sites in Germany: Leipzig Herzzentrum, Kerckhoff-Klinik Bad Nauheim, Freiburg UniversitätsSpital, Westdeutsches Herzzentrum Essen and Universitäres Herzzentrum Hamburg. Forty (40) patients with severe aortic stenosis were recruited and treated with ACURATE TA™. The average age of treated patients was 83 years with a mean Logistic EuroScore of 21.5% and STS Score of 9.0%.

Results
Successful valve implantation with the ACURATE TA™ occurred in 38 patients (95.0%). One patient received a valve-in-valve using a commercially available transapical valve and one patient was converted to sAVR. Only one patient required a new pacemaker post-implant. 30-day mortality was 12.5% including 3 deaths from non-valve-related respiratory complications. Comprehensive 30-day results will be presented at the Dallas / Leipzig International Valve conference in December 2010.

Dr. Joërg Kempfert of Leipzig Herzzentrum commented: “The ACURATE TA™ is truly intuitive, easy to use, reliable and covers the full spectrum of severe aortic stenosis. We look forward to the Pilot study to confirm the excellent results obtained in this comprehensive FIM study.”

Laura Brenton, VP Clinical / Regulatory Affairs, added: “The ease of use of the ACURATE TA™ was acknowledged by all physicians participating in the study. Additionally, the learning curve was significantly shorter than that of competitive systems. Furthermore, the robust size of the FIM allows for comparison of its initial data to published statistics from competitors suggesting comparable or improved initial outcomes.”

Jacques R. Essinger, CEO of Symetis, added: “ACURATE™ TA is the second generation TAVI system with the largest clinical experience to date. We are building on this competitive advantage by soon beginning a pilot clinical study, a major step toward achieving European compliance and the CE mark.”

About Symetis
Symetis SA (www.symetis.com) is a private Swiss company developing innovative, minimally invasive heart valve replacement solutions. Symetis’s Acurate TA™ system, based on proprietary geometry and delivery technology, is in clinical trials and is well positioned to target the ca. $2 billion transcatheter aortic valve implantation (TAVI) market. The company is financed by leading European venture capital firms including Truffle Capital, Novartis Venture Fund, Aravis Venture, Wellington Partners, Vinci Capital, Banexi Venture and BiomedInvest.

WOODLAND HILLS, CA–(Marketwire – September 22, 2010) –  In August 2010, the Joint Commission on the Accreditation of Health Care Organizations (JCAHO) granted accreditation to Optimum Performance Institute (OPI), a highly-individualized therapeutic/educational and residential treatment program helping young adults, aged 17 – 25, achieve their goals in education, job skills, and improved social interactions. Located in Woodland Hills, CA, OPI’s coed program helps its participants understand and resolve those issues that have kept them from moving forward in their lives. 

The accreditation from The Joint Commission makes OPI one of the first programs in the country focusing exclusively on helping young adults transition into adulthood to receive this prestigious status. Receiving JCAHO’s national accreditation is the highest level of achievement a health care organization can receive signifying its overall commitment to quality of care and services.

“The JCAHO accreditation is a huge honor,” states Robert F. Fischer, M.D., OPI executive director. “It requires key competencies in all areas of performance and validates that we operate at the highest level of professionalism possible with an ongoing commitment to continuing to improve the services we deliver to our participants. Accreditation from JCAHO sets OPI apart from other facilities of our kind in receiving this prestigious accreditation.”

To receive accreditation, a healthcare organization must submit to a substantial review process of its practices to ensure that it complies with JCAHO standards. The Joint Commission accredits over 17,000 health care organizations and programs in the United States. A majority of state governments recognize JCAHO accreditation as a condition of licensure and the receipt of Medicaid reimbursement.

By voluntarily choosing to participate in the accreditation process, OPI asked to be measured against the national standards to which health care professionals agree are most conducive to providing quality care in organized health care delivery settings.

Click here to see all recent news from this company

Email a Friend

Printer Friendly Version

Latest News Releases

WOODLAND HILLS, CA–(Marketwire – September 21, 2010) –  Great American Group, Inc. (OTCBB: GAMR), a leading provider of asset disposition, valuation and appraisal services, today announced a complete disposition of all medical and support equipment assets of a now-closed Springfield, Ohio hospital.

Great American Group will conduct a public auction sale of the 100+ bed facility on behalf of Community Mercy Health Partners piece-by-piece in an online-only, timed sale event, with bidding open from September 23 through 28, 2010.

Having conducted complete asset dispositions and valuations for dozens of hospitals and clinics of all sizes over the last decade, Great American Group is uniquely positioned to perform this specialized sale. The asset management firm has garnered a wealth of experience and built a strong following of healthcare equipment buyers throughout the modernized world. 

“Good, used medical equipment is in demand everywhere, so it is not uncommon for us to see the healthcare assets we sell at auction redeployed on a global scale,” commented Mark Weitz, President of Great American Group’s Wholesale and Industrial Services. “When a hospital such as this closes, it results in a positive opportunity for other regional hospitals, clinics, and specialized healthcare facilities to expand or modernize their operations at an economical cost,” Mr. Weitz continued.

A Great American Group online auction allows buyers to bid from their computer over the course of the timed sale event. Buyers who tender the highest bid on each item or lot offered will be awarded those items after the close of the auction. Inspection of all items will take place at 1343 N. Fountain Boulevard in Springfield, Ohio on Wednesday, September 22, or by appointment. Bidding will close on September 28, 2010.

About Great American Group®

Great American Group, Inc. is a leading provider of asset disposition solutions and valuation
and appraisal services to a wide range of retail, wholesale and industrial clients, as well as
lenders, capital providers, private equity investors and professional service firms. Great
American Group has offices in Atlanta, Boston, Chicago, Dallas, London, Los Angeles, New
York, and San Francisco. www.greatamerican.com

*Great American Group and the Eagle Design are trademarks registered in the US Patent and
Trademark Office and are exclusive property of Great American Group, Inc.

GAMR-G

BALTIMORE, MD–(Marketwire – September 21, 2010) –  The Harry and Jeanette Weinberg Foundation, one of the largest private foundations in the United States, today celebrates the largest gift to a long-term care center in the Foundation’s history.

The $10 million pledge is part of a $31 million construction project at Levindale Hebrew Geriatric Center and Hospital that will set a new standard for excellence in elder care. The occasion will be marked with a ceremony Tuesday, September 21, at 5 p.m. on the newly named Harry and Jeanette Weinberg campus at Levindale.

“Harry Weinberg was always concerned about the lives of poor older adults, and his commitment is carried out by the Foundation which bears his name,” said Barry I. Schloss, the Foundation treasurer, and one of its trustees. “The Foundation is proud to partner with Levindale on this groundbreaking project.”

With completion expected in the spring of 2012, the new Levindale will be a cheerful, inviting residence providing a comfortable, elegant and friendly atmosphere.

The Harry and Jeanette Weinberg Foundation is dedicated to assisting the poor, meeting basic needs such as shelter, nutrition, and health with special emphasis on older adults and the Jewish community.

About The Harry and Jeanette Weinberg Foundation
The Harry and Jeanette Weinberg Foundation annually distributes approximately $100 million to a wide range of charitable organizations. The Foundation is dedicated to assisting the poor through operating and capital grants to direct service organizations primarily located in Maryland, Hawaii, Northeastern Pennsylvania, New York, Israel, and the Former Soviet Union. Grants are focused on meeting basic needs such as shelter, health and socialization, nutrition, and on enhancing an individual’s ability to meet those needs. Within that focus, emphasis is placed on older adults and on the Jewish community. The trustees, some of whom also serve as executive officers of the Foundation, are Alvin Awaya, Judge Ellen M. Heller, Robert T. Kelly, Jr., Barry I. Schloss, and Chair of the Board Donn Weinberg. Rachel Monroe serves as the Weinberg Foundation’s President. For more information please go to www.hjweinbergfoundation.org.

BETHESDA, MD–(Marketwire – September 21, 2010) –  Coventry Health Care, Inc. (NYSE: CVH) announced today that it will release third quarter 2010 financial results on Friday, November 5, 2010. Allen Wise, Coventry’s Chief Executive Officer, will be hosting a conference call at 8:30 a.m. ET on that day. To listen to the call, dial toll-free at (877) 591-4959 or, for international callers, (719) 325-4748. Callers will be asked to identify themselves and their affiliations. 

The conference call will also be webcast from Coventry’s Investor Relations website at www.coventryhealthcare.com. Coventry asks participants on both the call and webcast to review and be familiar with its Securities and Exchange Commission filings. A replay of the call will be available for one week at (888) 203-1112 or, for international callers, (719) 457-0820. The access code is 5680841.

Coventry Health Care (www.coventryhealthcare.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers’ compensation services companies.  Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators. 

LONDON–(Marketwire – September 21, 2010) –  The Autism Treatment Center of America is launching a free lecture series in U.K. cities in October. The lecture details highly effective treatment techniques for use by parents of children with Autism and related developmental difficulties. Lecture attendees have seen miraculous changes in their children since attending.

“I would urge parents to grab the chance to go to a lecture,” said Mark O., whose son was diagnosed with Autism. “The Son-Rise Program has seen my six-year-old’s abilities improve so dramatically in the last year, that he is almost ready for a mainstream school. It helped him improve his verbal skills, flexibility and emotional ties, and improved the quality of life for me, my wife and our 10-year-old daughter.”

Lee J. agrees. “Prior to attending Raun’s lecture, my son Adam, who had been diagnosed with Autism, had no language, rarely looked at us, avoided physical contact, and flapped his hands,” he says. “My wife and I went to Raun’s lecture and it felt like someone had finally given us the answer. Four years later, our son has progressed beyond our expectations. He speaks in full sentences now! When I hear him say ‘Night, night Daddy,’ it melts my heart. That two-hour lecture was a turning point for all of us.”

Attendees will be given techniques to use immediately from The Son-Rise Program at the lecture, presented by Raun K. Kaufman, international Autism lecturer and Director of Global Education of the Autism Treatment Center of America. Mr. Kaufman is the subject of the book Son-Rise: The Miracle Continues, which details his own recovery from Autism.

Register now at: http://www.AutismHelpuk.org/uk. Lectures are free to the public. NOTE: Children cannot be accommodated at the lectures.

LONDON — 9 October, 10 a.m. & 3 p.m. — Regents College
LONDON — 14 October, 6:30 p.m. — Regents College
LONDON — 16 October, 10 a.m. & 3 p.m. — UCL Institute of Child Health
MANCHESTER — 2 October, 10 a.m. — University of Salford
LEEDS — 3 October, 3 p.m. — Leeds College of Music
SHEFFIELD — 5 October, 6:30 p.m. — Ponds Forge
LEICESTER — 7 October, 6:30 p.m. — Leicester Tigers Walker Stadium
BIRMINGHAM — 10 October, 3 p.m. — Aston University
NOTTINGHAM — 12 October, 6:30 p.m. — St. Peter’s Church

Click here to see all recent news from this company

DENVER, CO–(Marketwire – September 21, 2010) –  Rose Pediatrics, a provider network dedicated to delivering true customer service to patients and families, this month launched RosePediatrics.com, a comprehensive health and wellness resource for families everywhere. This innovative and informative website offers advice from leading pediatricians to help parents make informed decisions about their children’s health.

“RosePediatrics.com leverages the expertise of leading pediatricians, which in turn, empowers parents to make educated decisions when it comes to their children’s health,” said Andrew Lieber, MD, co-founder and chief medical officer of Rose Pediatrics.

A popular feature available at RosePediatrics.com is the dosages resource. This interactive tool provides accurate dosage information — in amounts and frequency — for common childhood medications depending on an individual’s age and weight.

“The website incorporates a steady stream of health and wellness advice from Rose Pediatrics physicians,” said Howard Lieber, co-founder and chief executive officer of Rose Pediatrics. “It’s designed to be a user-friendly tool for families across the country.”

RosePediatrics.com offers advice related to caring for kids from birth to age 21; ranging from jaundice in newborns, to managing flu shots and other immunizations, to recognizing the symptoms of commonly seen childhood illnesses, among other topics. Also available on the educational website are how-to articles, answers to FAQs, and book reviews focused on children’s common health issues. In addition, RosePediatrics.com offers engaging, helpful blogs written by parents and some of the medical providers who are sharing their stories, successes, counsel, and concerns.

The site’s goal is to empower parents to better understand their child’s illness or injury and visit their pediatricians armed with the appropriate questions.

Rose Pediatrics, which operates two clinics in Colorado, launched the user-friendly website as an extension of the company’s mission: “our family caring for your family.” This family run, service-based medical provider network plans to open six additional clinics in the Denver metro area over the next several years.

For more information, visit RosePediatrics.com.

About the Rose Pediatric Provider Network
Rose Pediatrics is a provider network dedicated to delivering true customer service to patients and families. Led by chief medical officer, Andrew Lieber, MD, the network’s pediatric team has more than 35 years of pediatric practice experience and 20 years of specialized training in asthma, diabetes, obesity, allergies, flu and other child health issues. Receiving the highest quality designations from every insurance company, the pediatric network aims to provide high quality treatment while delivering efficiency and cost effectiveness to patients. As a family-run organization with Dr. Lieber’s brother, Howard Lieber, serving as CEO, Rose Pediatrics is committed to treating each patient like family. Through its online resource, RosePediatrics.com, the Rose Pediatric Provider Network is dedicated to providing education and services to families across the nation. For more information about Rose Pediatrics’ clinics in Denver and Highlands Ranch, or to find a pediatrician, visit RosePediatrics.com.

Click here to see all recent news from this company

SALT LAKE CITY, UT–(Marketwire – September 21, 2010) –  What if health insurance was like auto insurance and “safe drivers” were eligible for discounts on their health care coverage? Now, because of new federal guidelines, “safe drivers,” or those who engage in taking better care of their health, can be rewarded with lower health insurance premiums.

A growing number of organizations are offering accountability-based wellness programs to their employees, rewarding those who participate by engaging in the improvement of their health, while employees who don’t participate continue to pay higher health premiums. Employers are finding that not only is the average employee showing improvements in measurable health indicators, but the wellness program adds no extra cost to the employer or the participating employee.

Health Behavior Innovations (HBI) is the founder of accountability-based wellness programs. According to CEO Darrell Moon, HBI’s innovative wellness program, the Apple Program®, has involved tens of thousands of participants, with more than 75 percent of eligible employees participating (including their spouses) with a customer satisfaction rating of more than 85 percent. With the new federal guidelines, companies can now design benefits programs that assist, support and engage participants differently according to their willingness to take accountability for their health. That’s where the Apple Program excels.

“Accountability makes the program work,” Moon said. “If you participate, you save money and generally become healthier. If you choose not to participate, you pay more. The whole thing works because those employees who opt in are not only saving money but they are losing weight, reducing blood pressure and generally enjoying healthier lives. And employers have a healthier workforce with no added cost to the company.”

Over the past five years, HBI’s total average biometric health scores per at-risk person have improved every year. For example:

• Blood pressure — Systolic pressure (while heart is contracting) dropped 5.9 mmHg each year, and diastolic pressure (heart resting) fell 3.7 mmHg each year.
• Glucose — declined 8.9 mg/dL each year.
• Triglycerides — fell 19 mg/dL each year.
• Total cholesterol — dropped 11 mg/dL each year.
• Bad cholesterol — declined 8.8 mg/dL each year.

In terms of body weight, according to AmericasHealthRankings.org the average American gains weight each year. In contrast, the average obese Apple Program participant loses weight each year. This represents a more than 300 percent difference in weight change between the average American and the average obese Apple participant.

The Apple Program doesn’t rely on financial incentives alone to help employees make lifestyle changes. The key to success is the personalized assistance each person receives from a dedicated health coach and having their progress tracked via an advanced Web portal.

“Bottom line: when employees choose to be engaged they see results and so do employers,” Moon said. “HBI is identifying the health care safe drivers and helping those who aren’t to become health care safe drivers, without raising costs.”

For more information about Health Behavior Innovations and the Apple Program, visit www.healthbehaviorinnovations.com and www.theappleprogram.com.

SAN FRANCISCO, CA–(Marketwire – September 21, 2010) – ORACLE OPENWORLD — Oracle (NASDAQ: ORCL)

News Facts

• Oracle today announced the launch of the Oracle Health Management Platform, a complete, open and integrated suite of unified solutions, combined with a framework on which providers and payors can build secure applications and services. This Platform can help to reduce administrative costs, gain insight into operations and patient outcomes, and enable more effective and secure interactions with patients, sales teams and enrolled members.
• The Oracle Health Management Platform provides organizations with validated and integrated solutions for business intelligence, interoperability, relationship management, and operations management. 
• Developed with an industry-tailored, hot-pluggable architecture, the Oracle Health Management Platform — which includes Oracle Database, Oracle Fusion Middleware and Oracle Applications — helps provider and payor organizations support immediate business requirements today while providing a clear, integrated framework to which they can add additional applications as business requirements change.
• The platform supports a broad range of healthcare applications and functions, including patient discharge management, provider referral analysis, patient outreach and relationship management, member enrollment and relationship management, medications reconciliation, chronic disease management and Thin Electronic Health Records.
• Oracle Health Management Platform enables providers and payors to expand interaction with patients and enhance care coordination. It also provides a more integrated foundation to support the diverse and ever-changing requirements of today’s health industry organizations.

Supporting Quotes

• “Healthcare providers and payors are looking for ways to extend their interaction with patients and members beyond the walls of healthcare facilities to drive more effective and cost-efficient care,” said Lynne A. Dunbrack, Program Director, Connected Health IT Strategies, IDC Health Insights. “To achieve this goal, they require flexible IT frameworks and integrated platforms that give them the ability to deploy new applications quickly, as needed to meet changing demand. Oracle Health Management Platform delivers a scalable foundation that supports efforts to reduce operational costs and enable accountable care.”
• “To fulfill the potential of healthcare reform initiatives and citizen health management, today’s healthcare industry requires greater levels of transparency and insight across the healthcare continuum to enable better care coordination and improved outcomes at lower costs,” said Marc Perlman, Global Vice President for Healthcare and Life Sciences, Oracle Healthcare. “Oracle Health Management Platform combines Oracle’s technology and services offerings to reduce costs while advancing provider and payor efforts to implement accountable care infrastructures, and improve patient interactions, collaboration, and outcomes.” 

Supporting Resources

• Oracle in Healthcare
• Follow Oracle Health Sciences on Twitter
• Join the Oracle Health Sciences Community on Facebook

About Oracle
Oracle (NASDAQ: ORCL) is the world’s most complete, open, and integrated business software and hardware systems company. For more information about Oracle, visit oracle.com.

Trademarks
Oracle and Java are registered trademarks of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

NEW YORK, NY–(Marketwire – September 21, 2010) –  The Patient Channel and the Newborn Channel, part of the nation’s largest hospital-based health television network, currently available in over 2,700 hospitals nationwide, today announced the addition of twelve exciting new programs designed to promote patient wellness and parenting success.

A survey* commissioned by the Patient Channel shows that 43% of Americans felt that they didn’t receive enough information regarding their own or a loved one’s condition during their last hospital stay, and hospitalized patients often have difficulty getting health information at the very time they want it most — at the point of care.

The new programs, which range in content from helping dads become more involved in infant care to how patients can finally quit smoking, deliver important health information and advice in an entertaining and engaging format that positively affects patient lifestyle decisions upon discharge.

All programs are developed by the Patient Channel and the Newborn Channel, with the clinical guidance and expertise of its distinguished medical advisors and review board. Videos are shot on location and feature national health experts and patient stories told by the patients and their physicians. This unique storytelling helps patients better understand and cope with what is required to manage their care.

“With the increases in fiscal restrictions and regulations, it is more difficult than ever for doctors and nurses to give each patient the personal care and attention they would like and as a result, the patient may miss out on important information,” said Dave Ross, Chief Operating Officer, Interactivation Health Networks. “We’ve added programs designed to help hospitals not only meet requirements for regulatory compliance and reimbursement but also supply patients with a source of poignant and credible advice.”

“The Patient Channel and Newborn Channel provide our nurses with the resources they need to supplement their patient and family education. It also gives us valuable tools to help us meet some of our regulatory requirements to provide mandated education to our patients,” said Beth Quinn-O’Neill, Director of Clinical and Community Education at Holy Name Medical Center, Teaneck, NJ, which has been participating in the network since 2002.

The following programs have been recently added and are now available in all participating hospitals:

NEWBORN CHANNEL

• Mommy Calls — Information on when new moms should call the doctor
• Mommy Don’t Smoke — A practical guide to quitting
• Shaken Baby Syndrome — Information on how to avoid a preventable tragedy
• Special Care for Preemies — A look at the special needs of premature newborns
• Baby’s Clean Home — Information about creating a safe and clean home for babies
• Keeping Baby Safe — Important safety information for new parents
• Dad’s Role with Baby — Pointers for Dads new to parenting

PATIENT CHANNEL

• Men’s Health: Advice to Baby Boomers — Health issues unique to male boomers
• Women’s Health: Advice to Baby Boomers — Health issues unique to female boomers
• Stop Smoking Today — A practical guide to quitting
• Living With Heart Disease — How to resume life after a heart attack and avoid readmission
• Preventing Flu and Pneumonia — The latest information, just in time for the cold and flu season

For a full listing of the Patient Channel’s programming please click here and for the Newborn Channel’s programming click here, or visit thepatientchannel.com and thenewbornchannel.com for more information.

*The Patient Channel Hospital Patient Education Survey was commissioned through ORC International. The survey was conducted among 1,025 American adults [509 men and 516 women] living in private households, age 18 years and older. The overall margin of error for the survey was +/- 3%.

About Interactivation Health Networks
The Patient Channel and the Newborn Channel are the most comprehensive in-hospital TV networks. Delivered directly to patient rooms and waiting areas, the Channels provide viewers with original, award-winning health programs and advertisers with the unique ability to integrate brand messaging with content that is compelling and endorsed by healthcare professionals. The Newborn Channel broadcasts baby care and postpartum programming for new parents, reaching 60% of new moms. The Patient Channel features both condition-specific and preventative health programming to empower and inform patients. The channels are currently available in over 2,700 hospitals nationwide. For more information, visit www.thenewbornchannel.com and www.thepatientchannel.com

ALISO VIEJO, CA–(Marketwire – September 21, 2010) –  CNS Response (OTCBB: CNSO) today announced that CEO George Carpenter will be presenting at JMP Securities Fifth Annual Healthcare Industry Conference to be held Monday, September 27, through Tuesday, September 28, at the New York Palace Hotel in New York, NY. Carpenter’s presentation time has been rescheduled to 10:30 a.m., Tuesday, September 28, 2010. Institutional investors wishing to schedule a one-on-one meeting with Mr. Carpenter may do so by contacting JMP Securities’ Kelly Weigel at [email protected].

About CNS Response
Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

Referenced-EEG was developed by physicians to provide objective, personalized, statistical data on patient neurophysiology. In clinical trials, physicians using rEEG^® data have consistently achieved superior clinical results compared to physicians using trial and error pharmacotherapy.

The Company recently announced publication of results from its most recent clinical trial in The Journal of Psychiatric Research, in which physicians using Referenced-EEG (rEEG^®) had success rates reaching 65 percent for patients with treatment-resistant depression.

To read more about the benefits this patented technology provides physicians, patients and insurers, please visit the CNS Response website, www.cnsresponse.com.

CAMBRIDGE, MA–(Marketwire – September 21, 2010) –  InterSystems Corporation today announced that the U.S. Army has awarded the company a Research, Development, Test, and Evaluation grant for a project that will enable health information exchange (HIE) among military and commercial healthcare providers via the Nationwide Health Information Network (NHIN). The grant will fund implementation, deployment and support of the InterSystems HealthShare™ platform for regional and national electronic health records. The global leader in software for connected healthcare, InterSystems provides advanced software technologies for breakthrough applications. 

The project will demonstrate the feasibility of efficiently implementing an integrated HIE between a Department of Defense (DOD) facility, the Madigan Healthcare System, and civilian partner organizations of the South Sound HIE. SSHIE was formed to organize and implement information exchange, in order to improve the health of the South Puget Sound community in the state of Washington. It includes MultiCare Health System, Franciscan Health System and Madigan.

Functionality provided by the proposed solution includes a regional Enterprise Master Patient Index, a Record Locator Service, and a bi-directional data exchange platform that provides for interoperability between Madigan, MultiCare, and Franciscan. “The DOD, Department of Veterans Affairs and other agencies have embraced the NHIN to facilitate information sharing on a national basis. This project will leverage that work for NHIN interoperability between Madigan and its private sector partners,” said Paul Grabscheid, InterSystems Vice President of Strategic Planning. “Reflecting our successful working partnership, InterSystems has provided the DOD and VA hospitals with multiple advanced software technologies to implement healthcare systems across the country. We appreciate the opportunity to work on an initiative that is another step forward to truly connected healthcare.”

“I see this initiative as contributing to the overall information exchange between our managed care partners and a DOD facility… in this case, Madigan,” said Rick Barnhill, Program Manager, Clinical Informatics at Madigan. “If, in the end, we have the ability to quickly find basic patient and health data that can be used either in the emergency room setting for patients who require urgent care, or in the standard outpatient setting when information relating to patients’ health is available to the contracted care provider, we will consider this project a success.”

About InterSystems

InterSystems is the worldwide leader in software for connected healthcare. With headquarters in Cambridge, Massachusetts, and offices in 25 countries, InterSystems provides advanced software technologies for breakthrough applications. InterSystems CACHÉ® is a high performance object database that makes applications faster and more scalable. InterSystems Ensemble® is a seamless platform for integration and the development of connectable applications. InterSystems HealthShare™ is a platform that enables the fastest creation of an Electronic Health Record for regional or national health information exchange. InterSystems DeepSee™ is software that makes it possible to embed real-time business intelligence capabilities in transactional applications.

InterSystems is the world’s #1 vendor of database and integration technologies for healthcare applications. InterSystems products are used by thousands of hospitals and labs, including all 14 hospitals on the Honor Roll of America’s Best Hospitals as rated by U.S. News and World Report. For more information, visit InterSystems.com.

About Madigan Healthcare System

Madigan Healthcare System is an ever-expanding care facility occupying more than 120 acres of land on Joint Base Lewis-McChord in Tacoma, Wash. With 57,000 beneficiaries, the medical center’s tri-service mission encompasses active duty, family members and military retirees residing in its 40-mile catchment area.

As one of the U.S. Army’s most state-of-the-art and technically advanced medical centers, Madigan is one of only three designated Level II trauma centers throughout the U.S. Medical Command (MEDCOM). Additionally, Madigan’s Andersen Simulation Center, which helps train thousands of doctors, nurses and medics each year, holds the distinction of being the first educational institution in the Department of Defense accredited by the American College of Surgeons. Finally, Madigan continues to consistently be named among the “100 Most Wired Hospitals and Health Systems” by Hospitals and Health Networks magazine. For additional information, go to http://www.mamc.amedd.army.mil/mamcinfo.cfm

About MultiCare Health System

MultiCare is a leading-edge, integrated health organization made up of four hospitals including Allenmore Hospital, Good Samaritan Hospital, Mary Bridge Children’s Hospital and Tacoma General Hospital, numerous primary care and urgent care clinics, multi-specialty centers, Hospice and Home Health services, and many other services. A not-for-profit organization based in Tacoma, Washington since 1882, MultiCare has grown over the years in response to community needs. Today it is the area’s largest provider of health care services, serving patients at 93 locations in Pierce, South King, Kitsap and Thurston counties. For additional information, visit www.multicare.org.

About Franciscan Health System
The Franciscan Health System, located in Washington State, is a faith-based organization affiliated with Catholic Health Initiatives, one of the largest non-profit health organizations in the United States.

Franciscan includes five full-service hospitals; a large primary-care and specialty-care medical group; in-home and inpatient hospice and palliative care; same-day surgery centers; occupational health and physical therapy clinics; and centers for advanced medicine that are distinguished by expertise and state-of-the-art technology. For more information, see www.fhshealth.org.

Click here to see all recent news from this company

IRVING, TX–(Marketwire – September 21, 2010) – VHA Inc., the national health care network, has created a new offering to support members’ efforts to improve patient flow within their organizations. Health care organizations are concerned about efficiently moving patients around and through their facilities because delays and bottlenecks cost money, resources and impact patients’ satisfaction. The Joint Commission expects hospitals to identify barriers to patient flow and to implement solutions that will improve patient flow.

VHA works collectively with hospitals’ multi-disciplinary teams to identify and implement strategies that simplify and improve patient flow using analytics, national benchmarks, a cultural assessment and onsite observations and interviews. Armed with a thorough appraisal gleaned from a wide array of benchmarks for procedure times, length of stay, mortality, complications, co-morbidities and readmission rates, the VHA team pinpoints specific improvement opportunities and creates a plan of action tailored to an organization’s needs.

“Health care organizations searching for a quick fix to patient flow problems have typically focused on their emergency department,” said Nik Fincher, vice president of Purchased Services Sales and Capital for VHA. “While many patient flow inefficiencies are more apparent in the ER, exhibited by diversions, temporarily keeping patients in hallways, patients leaving without being seen, etc., organizations that have developed successful solutions recognize that patient flow is a complex issue that requires a comprehensive, enterprise-wide approach. VHA’s team of experts and portfolio of suppliers offer effective, results-oriented solutions to patient flow problems.”

VHA supports member efforts to streamline operations and enhance workflow by helping members improve patient arrival and transport logistics, patient tracking during their stay, room cleaning, turn time for operating rooms and patient rooms and discharge procedures.

VHA member Sharon (Pa.) Regional Health System engaged VHA supplier Sodexo for various support services and has since added other services including patient transport management.

“We’ve definitely seen increased patient satisfaction with the implementation of our central transport department,” says Sam Kudelko Jr., senior director of Support Services for Sharon Regional. “Patients arrive for their appointments on time, which prevents the snowball effect that happens when one patient runs late. The number of transports handled by nursing has decreased dramatically, allowing nurses to concentrate on patient care — translating into improved quality of care.”

As part of this services solution, VHA provides hospitals and non-acute care facilities with savings opportunities on a broad range of value-added services that help streamline operations, improve staff efficiency, reduce overall costs and assist with HIPAA compliance. For more information on VHA’s Patient Flow Collaborative please visit https://www.vha.com/Solutions/Contracting/Pages/PurchasedServicesOverview.aspx

About VHA — VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. In 2009, VHA delivered record savings and value of $1.47 billion to members. Formed in 1977, through its 16 regional offices, VHA serves 1,400 hospitals and more than 30,000 non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

NEW YORK, NY–(Marketwire – September 21, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com), a leading provider of Personal Health Records (PHRs) and electronic document imaging and management systems for healthcare professionals, today announced that Robert H. Lorsch, the Company’s Chairman and CEO, will be a featured speaker at the Health Technology Investment Forum (www.ihealthtran.com) taking place today at the Westin New York at Times Square. Lorsch’s presentation will outline the benefits for investors in the Electronic Health Records and Electronic Medical Records industries, of which the federal government has allocated over $42 billion for healthcare information technology (HCIT) over the next several years.

“MMRGlobal represents an opportunity for entrepreneurs with emerging growth companies in health information technology to attract the capital and visibility to maximize their prospects,” Lorsch said. “From personal experience, I understand how difficult it is for people with good ideas to execute on them without proper infrastructure and resources. We will offer selected companies the tools to build out their products and sell into the ever-expanding government and consumer health information markets.”

“Health IT represents an opportunity for investors to take advantage of the momentum created by the Obama Administration and the focus on reducing the cost of healthcare through computerized medical records. Our business plan includes a growth strategy of acquisitions to create a leadership position in this emerging marketplace,” added Lorsch.

MMRGlobal is uniquely positioned as a market leader in Personal Health Records with the Company’s MyMedicalRecords.com PHR (www.mmrvideos.com ). A recent Wall Street Journal study found that over $51 billion is available for investment by the end of 2011 from American private equity firms. Coupled with the fact that federal legislation mandates everyone in the U.S. to have an electronic health record by 2014, this offers investors and companies like MMRGlobal the ability to participate in the consolidation of a new industry.

About MMRGlobal

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Click here to see all recent news from this company

WATERLOO, ONTARIO–(Marketwire – Sept. 21, 2010) – Client Outlook, an emerging leader in healthcare IT, announced today that is has been awarded its Class II Medical Device License by Health Canada for its eUnity™ product.

eUnity™ is a zero footprint medical image viewer that provides healthcare professionals with secure access to diagnostic images such as X-rays, CT, MRI and nuclear medicine scans from any Internet-enabled location. Where in the past, clinicians have been forced to rely upon expensive, specialized equipment to view and share medical images, limiting access and collaboration, eUnity™ allows clinicians to view diagnostic quality images from any Web browser while using the Internet to directly collaborate with other medical professionals within a hospital setting or in other locations.

Client Outlook’s Class II Medical Device license, granted on September 14, 2010, legally permits clinicians using a calibrated monitor to use information displayed by eUnity’s™ viewer for patient diagnosis. The announcement comes on the heels of the Client Outlook’s ISO 13485 certification, received in June, 2010, a prerequisite for the Class II Medical Device license.

“eUnity™ significantly broadens access to diagnostic images within the healthcare enterprise improving efficiency of patient treatment, speeding access to care, and lowering cost to hospitals. In the past, clinicians were required to use high cost, specialized software or workstations to view images, and access was typically very limited –,” says Steve Rankin, Client Outlook president and CEO. “With eUnity™, hospitals can now inexpensively grant health professionals access to diagnostic quality images from virtually any workstation with a calibrated monitor.

“In addition to greatly expanding access to critical diagnostic images for purposes of diagnosis, we believe eUnity™ will play an instrumental role in bringing collaboration back into the patient diagnosis process. Using modern age technology, we’ve created a ‘virtual lightbox’ environment where physicians, radiologists and other healthcare professionals can collaborate in real time regardless of location. They can view images simultaneously and share mouse clicks and other gestures to enrich communication.” 

About Client Outlook

At Client Outlook we’re building innovative IT solutions that provide Health Professionals with secure access to the information they need at the point of care. For more information about our company and our product, eUnity, visit us on the web at www.clientoutlook.com

BOHEMIA, NY–(Marketwire – September 21, 2010) –  Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the appointment of a National Sales Director. Tom Bridges is a veteran sales and marketing executive with over 28 years of experience in the medical device industry. He has a proven track record of success in various markets such as cardiovascular surgery and critical care (American Edwards), neurosurgery (Image-Guided Neurologics, which was acquired by Medtronic, and StarFix), minimally invasive surgery (Unisurge and Innerdyne, which was acquired by US Surgical) and critical blood products (Haemonetics).

“We are delighted that Tom has joined us at Vycor,” commented Kenneth T. Coviello, Vycor Medical, Inc.’s CEO. “He brings tremendous experience in sales of devices critical to surgeons in the operating room, but also his own clinical experience as a US Naval Hospital Corpsman, which have provided him with the ability to build strong relationships with key physicians. Tom has also played a key role in new product development and introduction throughout his career and will continue to contribute in this way.”

ViewSite^™ Brain Access System (VBAS) medical device continues to gain US and international distribution with the addition of several new partners to its worldwide distributor network. In the US: Day Surgical, covering states in the northwest; Focus Group, covering Ohio, Michigan and Kentucky; and Novus Group, covering states in the southwest. Internationally: Xycorp, Inc. in Canada, PO Medica in Scandinavia and Aurora BioScience in Australia. Vycor’s distribution partnerships now cover approximately 70% of the US population and internationally its partnerships also encompass the Benelux, Spain, Italy, Greece, China, Hong Kong, Taiwan and South Korea. Vycor and its partner for China, Devon Medical, Inc., have recently completed the filing with China’s State Food and Drug Administration (SFDA) for the sale of VBAS in China.

“We are very excited with the growing recognition of our ViewSite retractor among highly respected distributors and surgeons,” notes Kenneth T. Coviello, Vycor Medical, Inc.’s CEO.

A paper recently issued by the Department of Neurosurgery, University of Illinois at Chicago, reported that the use of VBAS during brain surgery “provides a unique means of deep visualization and even force distribution of the retracted brain tissue… allowing one to achieve safe access to deep intracerebral lesions and decrease the rate of retraction-related complications.” The paper also states that “although the retractors were originally designed for the removal of deep subcortical tumors they may be used to access and evacuate intracerebral hematomas.” A leading university teaching hospital has also submitted for publication an evaluation paper outlining its clinical experience with VBAS. Vycor anticipates that this will be published shortly.

VBAS was designed to offer better deep brain access by causing less tissue trauma and allows for excellent binocular visualization of the surgical target and surrounding tissue — objectives among neurosurgeons world-wide. Citing the critical need for such an advance, Coviello continues, “Most are shocked to learn that brain retraction technology has not significantly changed in over 50 years. Where other forms of diagnostic and operative procedures have evolved by leaps and bounds, this crucial instrument has remained virtually unchanged. It’s common knowledge among brain surgeons that existing ‘ribbon’ or ‘blade’ retractors can cause brain tissue damage and/or potentially prolonged patient recovery. Given the estimated 600,000 brain surgeries conducted annually worldwide, this is a very significant and sizeable problem that our VBAS is now directly — and aggressively — addressing through a solution that Vycor believes is also fiscally sound.”

About Vycor Medical, Inc.
With corporate headquarters in Bohemia, NY, Vycor Medical, Inc. (OTCBB: VYCO) is a medical device company committed to making brain, spinal and other surgical procedures safer and more effective. The company’s flagship, Patent Pending ViewSite™ Surgical Access Systems represent an exciting new breed of retraction technology that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor’s innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(K) clearance for brain and spine surgeries, and CE marketing and HPB licensing in Canada. 

For the latest information on the company, including media and other coverage, and to learn more, please go online at www.VycorMedical.com.

Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast,” “anticipate,” “estimate,” “project,” “intend,” “expect,” “should,” “believe,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the abovementioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

PLEASANTON, CA–(Marketwire – September 21, 2010) –  Polycom, Inc. (NASDAQ: PLCM), a global leader in telepresence, video and voice communications solutions, today expanded Polycom’s leadership in voice over Wi-Fi (VoWi-Fi) products with next-generation Polycom® SpectraLink® 8400 series handsets for wireless voice and data applications that transform mobile unified communications (UC) in the workplace. The new Polycom SpectraLink 8400 series are the first in the industry to feature a revolutionary standards-based application platform, the most reliable form factor for enterprise use, an integrated barcode reader, Polycom’s renowned voice quality, and the industry’s broadest interoperability with 802.11a/b/g/n wireless infrastructure and market-leading UC platforms.

The SpectraLink VoWi-Fi telephones allow people to stay in contact and easily access important data from any location within the enterprise Wi-Fi network. The new solutions are designed to improve productivity and responsiveness of mobile workers, meet the critical communication needs in the healthcare, industrial, and retail markets, and deliver the industry’s lowest total cost of ownership — up to 33 percent lower than competing systems.

“Polycom is taking enterprise-grade VoWi-Fi to a higher level of functionality and performance with the introduction of the 8400 series handsets,” said Craig Mathias, principal, Farpoint Group, an advisory firm specializing in wireless communications and mobile computing. “The SpectraLink 8400 incorporates all of the key features enterprises are looking for in wireless handsets, including durability and ease of use, and also includes support for critical business applications through a powerful and flexible thin-client approach. And, of course Polycom’s reputation for building rugged, reliable products will put these new handsets on the short list across a huge range of applications.”

“Having access to people and data when and where you need it is important for any business, but is mission-critical in environments like hospitals, manufacturing facilities and large retail stores,” said Jim Kruger, Polycom vice president of Solutions Product Marketing. “Polycom SpectraLink handsets are the gold standard in wireless workplace mobility and we are raising the bar again with the 8400 series in terms of voice quality, reliability, application support and open standards-based interoperability.”

Support for mission-critical industry applications
The Polycom SpectraLink 8400 series’ open application platform and developer-friendly browser capabilities support enterprise and industry-specific applications such as nurse call in hospitals, inventory control applications in retail, and equipment monitoring systems in manufacturing. The phones are available with an integrated barcode reader delivering a revolutionary voice, application and data capture solution unlike any currently available platform in the market. For example, in a hospital environment, the integrated barcode reader and interface allows a nurse to quickly scan and transfer barcode information from a prescription from the phone. This supports barcode medicine administration best practices, which can reduce medical errors by up to 93 percent¹.

“Polycom is addressing Adventist Health’s demanding requirements by providing a platform for application support without compromising the durability, telephony features and voice quality we expect from our SpectraLink handsets,” said Scott Mahnke, telecom coordinator, Information Technology Services at Adventist Health. “We’re looking forward to deploying the 8400 series handsets throughout the organization, because they will have an immediate impact on meeting our initiatives for improved care, zero errors and greater patient satisfaction.”

Customer-driven design for ease of use and enhanced productivity
The Polycom SpectraLink 8400 series were designed with extensive customer input. The phones feature a large color display and simple, intuitive user interface, enterprise-grade durability, and broad accessory support for battery packs, headsets, etc.

Lowest total cost of ownership vs. competition
Through lower administrative costs, superior reliability and a more extensive warranty program, Polycom delivers up to 33 percent lower total cost of ownership than competing solutions. The Polycom SpectraLink 8400 series also delivers greater functionality through the combined power of two-way radios, pagers, barcode scanners, intercoms, and high-quality conferencing in a single fully-integrated device. It offers simple provisioning and management, and best-in-class warranty, maintenance and service offerings for long-term investment protection.

Broadest standards-based interoperability for greatest investment protection
The phones feature an integrated 802.11a/b/g/n radio with Polycom Voice Interoperability for Enterprise Wireless (VIEW) Certified performance on leading, enterprise-grade wireless LAN infrastructure platforms, as well as extensive enterprise call server support for a wide range of UC platforms.

The Polycom SpectraLink 8400 series handsets will begin shipping in the first half of 2011 through certified Polycom reseller partners. For more information, visit www.polycom.com/sl8400.

About Polycom
Polycom, Inc. (NASDAQ: PLCM) is a global leader in unified communications solutions with industry-leading telepresence, video, voice and infrastructure solutions built on open standards. Polycom powers smarter conversations, transforming lives and businesses worldwide. Please visit www.polycom.com for more information or connect with Polycom on Twitter, Facebook, and LinkedIn.

¹Source: The Journal of Healthcare Information Management

© 2010 Polycom, Inc. All rights reserved. POLYCOM®, the Polycom “Triangles” logo and the names and marks associated with Polycom’s products are trademarks and/or service marks of Polycom, Inc. and are registered and/or common law marks in the United States and various other countries. All other trademarks are property of their respective owners.

Click here to see all recent news from this company

SAN FRANCISCO, CA–(Marketwire – September 21, 2010) –  Rothman Healthcare Corporation (Rothman) today announced the appointment of Richard Sommer as Chief Executive Officer. “Richard is a natural fit for our company because he shares our passion for leveraging the new digital infrastructure in medicine to save lives and lower costs and because of his strong track record and background in healthcare information technology,” said Michael Rothman Ph.D., Co-Founder and Chief Science Officer. “We’ve spent over six years researching and developing our product and with Richard’s proven leadership, we can bring Rothman Healthcare into a burgeoning marketplace seeking true ‘meaningful use’ tools.”

Mr. Sommer has over 20 years of executive experience with 12 in the field of healthcare. He served as Co-Founder and CEO of De La Cruz Occupational Healthcare, Inc. and Medchannel, Inc., Chairman of the Committee for Hospital and Provider Reimbursements for the State of California, and Healthcare Economist for the State of California. As a seven-time CEO of both public and private companies, Mr. Sommer has demonstrated the ability to create strong profitable growth, substantially increase shareholder value, and bring revolutionary technologies to the marketplace. While CEO of HomeGain.com, Mr. Sommer grew revenues 250% and led the sale of the company for 29 times earnings, creating over $108 million in shareholder value. While at De La Cruz, Mr. Sommer grew revenues and earnings for ten consecutive years between 30-100% annually.

“Rothman has a long-standing commitment to improving patient care,” said Dr. G. Duncan Finlay, Chief Medical Officer and former CEO of Sarasota Memorial Hospital. “Richard understands our mission, our market and how to bring Rothman’s product to caregivers across the country.”

“I am excited to work with Rothman Healthcare,” said Sommer. “It combines my expertise in healthcare and my experience of growing promising companies with big ideas into big market players. Rothman’s technology has the potential to revolutionize the practice of medicine. I want to be a part of that paradigm shift.”

About Rothman Healthcare Corporation

Since 2004, Rothman Healthcare Corporation has been developing the Patient Condition Tracker to bridge gaps in continuity of care. Rothman’s software application uses electronic health record (EHR) data to highlight subtle declines in patient health and alert physicians in snapshot form. Rothman’s software application draws data from a hospital’s EHR system to generate and display a health score based on vital signs, nursing assessments and lab results, in a user-friendly and color-coded graphical format. The software allows clinicians to more easily understand patient conditions, offering the ability to see multiple patient graphs simultaneously for a high-level overview of a whole unit.

Rothman Healthcare Corporation is committed to improving quality and efficiency in patient care through innovative, patient-centric software enabling healthcare professionals to easily access critical and actionable patient health data. For more information, visit www.rothmanhealthcare.com.

NEW YORK, NY–(Marketwire – September 21, 2010) –  Emmy award-winning actress Claire Danes joined millions of people who’ve added their thumbprints to a unique petition at Grand Central Terminal, led by global humanitarian organisation Save the Children.

For downloadable photos, video and other supporting documents please visit: http://www.multimedianewscenter.com/savethechildren/three-million-give-thumbs-up-to-saving-childrens-lives

The thumbprint mosaic was designed by New York-based artist Ian Wright and represents the support of three million people from 40 countries who have taken part in Save the Children’s EVERY ONE campaign. The campaign aims to put pressure on world leaders meeting at the United Nations in New York, to do more to stop children dying needlessly of preventable and treatable causes.

The thumbprints will be handed over to a high level representative of the United Nations during the summit this week to review progress on the Millennium Development Goals, the internationally agreed targets to tackle poverty. Save the Children is calling for an action plan to be agreed to by all governments, to reach the Millennium Goal of cutting child deaths by two thirds by 2015. Hitting this target would save the lives of 15 million children by 2015, the charity said. It would involve improving children’s access to basic health care, nutrition, water and sanitation and education.

For more information, please visit www.everyone.org for the global EVERY ONE campaign and www.goodgoes.org in the U.S.

Click here http://www.multimedianewscenter.com/savethechildren/three-million-give-thumbs-up-to-saving-childrens-lives for access to:

• Footage of NYC Unveil Event
• Visuals of the Thumbprint Installation
• Photos of Emmy Award-Winning Actress Claire Danes
• B-roll of Claire adding her thumbprint
• Photos and B-roll of visual petition
• Soundbites w/ Emmy Award-Winning Actress Claire Danes
• Soundbites w/ Jasmine Whitbread, CEO, Save the Children International
• Other supporting documents and photos

SAN FRANCISCO, CA–(Marketwire – September 21, 2010) –  Pebble Project National Conference — AeroScout, the leading provider of Unified Asset Visibility for the healthcare industry, today announced that Laguna Honda Hospital & Rehabilitation Center has deployed AeroScout’s Patient Safety, Staff Safety and Asset Tracking solutions at its state-of-the-art skilled nursing facility set to open later this year. The AeroScout solutions are part of Laguna Honda’s initiative to create the safest possible environment, while providing its residents with an open lifestyle that fosters community and independence. At a conference today hosted by the Center for Health Design on the latest advances and best practices in healthcare design, Laguna Honda will showcase its new facility, including its AeroScout Wi-Fi RTLS implementation, as a model for leading organizations from around the country to learn from and emulate.

Operated by the San Francisco Department of Public Health, Laguna Honda Hospital & Rehabilitation Center provides skilled nursing and rehabilitation services to a diverse, safety net population. Located on a 62-acre campus, it is one of the largest acute care skilled nursing facilities in the United States and represents extensive commitments by the city to therapeutic care for seniors and adults with disabilities.

In 2003, the city broke ground on the construction of a complete replacement of the main Laguna Honda facility. The vision for the new 500,000 square-foot facility was to provide housing and community-style living, with the highest level of independence, for Laguna Honda’s hundreds of residents by constructing the most technologically advanced, efficient, flexible, humane and natural facility in the world. In planning the project, Laguna Honda incorporated many advanced concepts derived from evidence-based design, recognizing the significant benefits it would have on the health and quality of life of residents.

Assisted by AeroScout’s Professional Services team, Laguna Honda implemented AeroScout’s Patient Safety solution at the new facility, including three residential buildings, to provide an additional level of safety for residents with cognitive impairments, such as Alzheimer’s. The potential for people with advanced dementia to put themselves in harm’s way make AeroScout’s RTLS solutions a particularly important part of Laguna Honda’s quality of care.

“Our goal is to provide the safest and most therapeutic environment, while encouraging independence and freedom of movement across the 62-acre campus,” said Larry Funk, Associate Administrator at Laguna Honda. “AeroScout impressed our selection committee with its unparalleled experience in the healthcare market and was the overwhelming choice of the participants. In addition, the intuitiveness of their many applications made it the unanimous choice among our clinician panel.”

With the consent of residents and their families, people who need an additional level of safety will wear AeroScout Wi-Fi Wristband Tags, which allow caregivers to determine their location quickly. In three residential buildings, the AeroScout solution is integrated with the Access Control systems, and it also triggers voice commands if residents approach certain exit points. The verbal messages remind residents in their native language not to leave their household or neighborhood by themselves. If a resident continues alone beyond these points, appropriate caregivers receive alerts via VoIP phones, pagers and AeroScout’s Instant Notifier application, which delivers pop-up windows on workstations.

In addition to displaying the location of the resident, the AeroScout solution shows a photo to help caregivers identify the person in need of assistance. The AeroScout solution leverages Laguna Honda’s Cisco Unified Wireless Network, and because the system is linked to the City of San Francisco’s network infrastructure, Laguna Honda has future plans to locate residents who need help anywhere in the city where network coverage is available, such as at bus and train stations.

Laguna Honda has also implemented AeroScout’s Staff Safety solution to help provide the safest possible environment at the new facility. The solution includes 1,400 Wi-Fi Badge Tags with call buttons, which are worn by caregivers. When a button is pressed, the solution routes notifications or emergency alerts to the appropriate team members.

Laguna Honda is currently deploying an additional AeroScout application to help with operational goals of improving the efficiency of asset management, increasing equipment utilization and ensuring that clinicians have the medical equipment they need when and where it is needed. AeroScout’s Healthcare Asset Tracking solution will help Laguna Honda staff monitor and optimize 3,000 pieces of critical equipment, including specialized beds, EKG machines, crash carts, diagnostic units and portable x-ray machines.

“Laguna Honda created a remarkable design achievement that will not only benefit its residents and community, but also sets the standard for patient safety and care that benefits the entire healthcare industry,” said Gabi Daniely, Vice President of Marketing and Product Strategy at AeroScout. “Laguna Honda has incorporated AeroScout’s Patient Safety solution into its business processes and integrated with its information systems, resulting in a seamless solution. We are proud to be part of this nationally-acclaimed project and to help this important organization in our local area meet its goals.”

About Laguna Honda Hospital & Rehabilitation Center
Laguna Honda is an acute care skilled nursing and rehabilitation center owned and operated by the San Francisco Department of Public Health. It provides personalized, culturally competent services to a diverse safety net population of 780 residents. Among its innovative programs are:

• An award-winning restorative care program

• The San Francisco Bay Area’s only HIV/AIDS skilled nursing program

• Monolingual care in Chinese and Spanish

• A safe and comfortable environment for people with Alzheimer’s and other dementias

• Rehabilitative services that include physical therapy, occupational therapy, speech therapy, and audiology

• Programming for adults with developmental disabilities

• An in-house hospice

• Care that combines medical and social support for people coping with the effects of stroke, traumatic brain injury and multiple sclerosis

About AeroScout
AeroScout is the market leader in Unified Asset Visibility solutions. Customers improve operational efficiency using AeroScout products that leverage standard Wi-Fi networks to track and manage the location, condition and status of mobile assets and people. AeroScout’s global customer base consists of leading hospital, manufacturing and logistics organizations, including many of the Fortune 500. The company invented the first Wi-Fi-based Active RFID tag, and today is widely recognized as leading the market in number of deployments and tags shipped. Headquartered in Redwood City, California, AeroScout has offices in Europe, the Middle East, Asia, Australia and Latin America. For more information, please visit www.aeroscout.com.

AeroScout is a registered trademark of AeroScout, Inc. Information is subject to change without notice.

MONTREAL, QUEBEC–(Marketwire – Sept. 21, 2010) – The Jewish General Hospital and Aurora Interactive Ltd., both of Montreal, Quebec, today announced the signing of a landmark sales contract. The three-year agreement will see the integration of Aurora’s mScope Education Suite and the mScope Clinical Image Sharing Suite at the Jewish General, a major teaching hospital affiliated with McGill University. The hospital intends to use the mScope suites to create a unique online education network for pathology research.

The project will be led by Dr. Alan Spatz, director of the Department of Pathology at the Jewish General Hospital, a senior investigator at the Lady Davis Institute for Medical Research, and Professor of Pathology and Oncology at McGill University. He is also co-director of the Integrated Cancer Training Program at McGill and Canada Research Chair in Molecular Pathology.

“With this agreement, McGill and the Jewish General Hospital have acquired the only digital suite that will allow us to achieve our ambitious goals,” said Dr. Spatz. “The melding of our unique expertise with Aurora’s products enable us to provide our students the best online pathology education available.”

“Aurora is pleased to partner with McGill University and Jewish General Hospital’s ambitious plans to take pathology education online and make it truly global” stated Pierre Le Fèvre, President and Chief Executive Officer, Aurora Interactive.

In September 2010, McGill University placed among the top 25 universities globally for the seventh consecutive year in the QS World University Rankings.

About the Lady Davis Institute for Medical Research at the Jewish General Hospital

The Lady Davis Institute for Medical Research (LDI), located in Montreal, Quebec, is the research arm at the Jewish General Hospital, and has strong academic ties to McGill University. With over 150 affiliated researchers, the LDI is one of the largest and most important biomedical research institutes in Quebec and all of Canada. Major breakthroughs have been made by LDI researchers in the areas of HIV/ AIDS, aging, cancer, vascular disease, epidemiology and psychosocial science, and have thereby contributed to the health and well-being of millions of patients in Montreal, across Quebec and around the world.

About the Jewish General Hospital

Now in its landmark 75^th year of providing Care for All, the Jewish General Hospital has been a mainstay of superior medical care for generations of patients of all backgrounds. One of Quebec’s largest and busiest acute-care hospitals, the JGH is committed to improving the quality of healthcare for all Quebecers in partnership with the provincial healthcare network. In this anniversary year, the Jewish General Hospital has redoubled its commitment providing patients the best possible care in a clean, safe and human-centered environment. The JGH is able to deliver these pioneering, innovative medical services by strengthening its role as a McGill University teaching hospital, by expanding and upgrading its facilities, and by pursuing cutting-edge research at the Lady Davis Institute for Medical Research. Website: www.jgh.ca.

About McGill University

McGill University, founded in Montreal in 1821, is Canada’s leading post-secondary institution. It has two campuses, 11 faculties, 10 professional schools, 300 programs of study and more than 35,000 students. McGill attracts 6,800 foreign students from more than 160 countries around the world. Almost half of McGill students claim a first language other than English – including 6,200 francophones – with more than 6,200 international students making up almost 20 per cent of the student body.

About Aurora Interactive Ltd.

Aurora Interactive has developed the leading web based software platform (mScope) for simplification, productivity and ease of communications. mScope’s Universal Web Viewer has collaborative tools to view medical slides and images anytime, anywhere, regardless of file format. The software has three applications to aid digital pathology web based communications needs: mScope Education, mScope Clinical, and mScope Universal Viewer. Aurora’s mission is to improve patients outcomes and help members of the medical community achieve their full potential by eliminating the learning, diagnostic and collaborative restrictions imposed by time and space. www.aurorainteractive.com.

MONTRÉAL, QUÉBEC–(Marketwire – 21 sept. 2010) – L’Hôpital général juif et Aurora Interactive Ltd., tous deux de Montréal, au Québec, ont annoncé aujourd’hui la signature d’un important contrat de vente. L’entente de trois ans permettra l’intégration de la plate-forme de communication numérique et visualiseur mScope éducation d’Aurora et le partage d’images cliniques à l’Hôpital général juif, un grand hôpital universitaire affilié à l’Université McGill. L’hôpital a l’intention d’utiliser les logiciels mScope pour créer un réseau d’éducation en ligne unique pour la recherche en pathologie.

Le projet sera dirigé par le Dr Alan Spatz, directeur du Département de pathologie de l’Hôpital général juif, chercheur principal à l’Institut Lady Davis de recherches médicales, et professeur de pathologie et d’oncologie à l’Université McGill. Il est également co-directeur du Programme intégré de recherche et de formation en cancer à l’Université McGill et titulaire de la Chaire de recherche du Canada sur la pathologie moléculaire.

« Avec cette entente, l’Université McGill et l’Hôpital général juif ont acquis la seule plate-forme numérique qui nous permettra d’atteindre nos objectifs ambitieux», a déclaré le Dr Spatz. « La fusion de notre expertise unique et des produits d’Aurora nous permettent d’offrir à nos étudiants la meilleure éducation de pathologie en ligne disponible. »

« Aurora est heureux de s’associer aux ambitieux plans de l’Université McGill et de l’Hôpital général juif de permette l’éducation de la pathologie en ligne et de la rendre véritablement mondiale », a déclaré Pierre Le Fèvre, président et chef de la direction, Aurora Interactive.

Au sujet de l’Institut Lady Davis de recherches médicales de l’Hôpital général juif

Situé à Montréal au Québec, l’Institut Lady Davis de recherches médicales constitue l’organe de recherche de l’Hôpital général juif et entretient des liens étroits avec l’Université McGill. Avec plus de 150 chercheurs affiliés, l’Institut est un des plus importants centres de recherche biomédicale du Québec, voire du Canada. Ses chercheurs ont réalisé des percées majeures dans les domaines du VIH et du sida, du vieillissement, du cancer, des maladies vasculaires, de l’épidémiologie et de la psychosociologie. De ce fait, ils contribuent à la santé et au mieux-être de millions de patients montréalais, québécois et étrangers. (site web : www.ladydavis.ca)

À propos de l’Hôpital général juif

Oeuvrant pour une 75e année à prodiguer des soins « Au service de tous », l’Hôpital général juif a été un pilier du traitement médical de niveau supérieur pour des générations de patients de toutes origines, de Montréal et de partout au Québec, et même de l’extérieur. Un des hôpitaux les plus grands et les plus achalandés de la province offrant des soins de courte durée, et mettant à profit son expertise et son expérience, l’HGJ reste déterminé à améliorer le niveau de soins pour tous les Québécois en travaillant en collaboration étroite avec le gouvernement et son système de soins de santé. Pour souligner cette année d’anniversaire, l’Hôpital général juif réaffirme son engagement à veiller à ce que les patients reçoivent des soins de la plus haute qualité dans un environnement propre et sécuritaire. L’HGJ a été en mesure d’offrir ces services pionniers et novateurs en renforçant son rôle comme hôpital d’enseignement affilié à l’Université McGill, en agrandissant et en modernisant ses installations, et en réalisant des études de pointe à l’Institut Lady Davis pour la recherche médicale. Pour en savoir plus, veuillez consulter www.JGH.ca

À propos de l’Université McGill

McGill est l’un des établissements d’enseignement supérieurs les plus prestigieux du Canada et la principale université de recherche du pays. Notre effectif étudiant, issu de 160 pays, est le plus international des universités canadiennes offrant des programmes de médecine et de doctorat. L’Université McGill, le plus ancien établissement universitaire de Montréal, a été fondée en 1821 grâce à un legs d’un riche marchand, James McGill. À l’origine modeste collège, McGill est aujourd’hui une université trépidante comme en témoignent ses deux campus, ses 11 facultés, ses quelque 300 programmes d’études et ses 35 000 étudiants, donc 6 200 francophones et 6 800 étudiants étrangers. L’Université compte aussi quatre hôpitaux d’enseignement d’où sortent chaque année plus de 1 000 professionnels de la santé.

À propos d’Aurora Interactive

Aurora Interactive a développé mScope, une plateforme performante de logiciels basée sur le Web pour la simplification, la productivité et la facilité des communications. Le visualiseur Web universel mScope a des outils de collaboration pour visualiser des lames microscopiques et des images médicales à tout moment, n’importe où, indépendamment du format du fichier. Le logiciel comprend trois applications pour l’aide de vos besoins de communication basés sur votre toile de pathologie numérique, mScope pédagogique, mScope clinique et le visualiseur universel mScope. La mission d’Aurora est de faciliter une meilleure santé des patients et d’aider les membres de la communauté médicale à réaliser leur plein potentiel en éliminant les contraintes d’acquisition des connaissances, de diagnostic et de collaboration imposées par le temps et l’espace. www.aurorainteractive.com

NEW YORK, NY–(Marketwire – September 21, 2010) – Allied Healthcare International Inc. (NASDAQ: AHCI), a leading provider of flexible healthcare staffing services in the United Kingdom, announced today that Sandy Young, the Company’s Chief Executive Officer, will be presenting at the Jefferies 2010 Global SpecPharma and European Healthcare Conference to be held October 5-6, 2010 at the Waldorf Hilton in London.

Allied’s presentation is scheduled for Wednesday, October 6, at 4:30 p.m. UK Time.

The presentation will be webcast live and will be available on the Investors section of Allied’s website at www.alliedhealthcare.com. For those who are not available to listen to the live broadcast, the presentation will be archived.

About Allied Healthcare International Inc.
Allied Healthcare International Inc. is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately 115 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care, nursing and care homes, and hospitals. For more news and information please visit: www.alliedhealthcare.com.

MARYVILLE, TN–(Marketwire – September 21, 2010) –  Asbury, Inc. announced that it will break ground on its St. Clair Apartments project at Asbury Place Maryville today. The groundbreaking will take place at 10:00 a.m. at the Asbury Place Maryville campus, 2648 Sevierville Road, Maryville, TN. The ceremony will include local officials and staff. Staff members who have been with Asbury for twenty or more years will also be honored. The public is invited.

With an estimated construction cost of $6 million, St. Clair Apartments at Asbury Place includes 48 new residential apartment homes, a new Wellness Center and Dining Room, and renovations to the existing Clubhouse.

The apartments will range in size from 900 to more than 1700 square feet, and residents have a choice of 1, 2 or 3-bedroom floor plans with walk-in closets, full kitchens, telephone, internet and cable hookups, built-in garbage disposals, dishwashers, washers and dryers and central heating and air. Other features include choice of interior colors, window treatments, skylights on upper floors, pocket doors, tray ceilings, optional fireplaces, smoke detection and sprinklers, screened porches, elevators, and under building garages with automatic door openers.

The groundbreaking is a milestone in making true enhancements to the retirement lifestyle at Asbury. Bistro-style and private dining, a brand-new Wellness Center, and fitness classes combine to make tangible Asbury’s vision of a person-centered approach to overall wellness.

“St. Clair is a direct response to what people fifty-five and better are looking for in residences at a community. Residences are becoming more personalized and customized, and they have accents and finishes that rival other new home construction. Senior living communities are upgrading their wellness centers in response to more residents focusing on fitness and a dedication to staying healthy longer. Restaurant-style and quality dining is also now the norm, including having an executive chef, fresh ingredients and more menu choices,” said Joy Evans, The Asbury Group’s Regional Director of Marketing.

Tesa Brown, Asbury Place Maryville Executive Director, added, “This is a much-anticipated day for Asbury Place Maryville. Residents at St. Clair will have an active lifestyle, a better lifestyle, and it’s exciting to see all the planning become reality. Asbury Place Maryville has a full continuum of on-site care, and St. Clair is now a significant part of that.”

Joseph Construction of Knoxville is the construction consultant and anticipates as many as 125 workers will be employed for the project.

Reservations are now being accepted for the apartments, and a welcome center on the Asbury campus provides further information. For a limited time, those who reserve a new apartment home receive Charter Member benefits, including the best selection of residential living style and location, preferential pricing, and invitations to special Members-only events.

About Asbury, Inc.
Founded in 1956, Asbury, Inc. manages a network of not-for-profit retirement communities and health care centers for individuals fifty-five or better in Maryville, Kingsport, and Johnson City, Tennessee. For more information, please visit http://www.AsburyPlaceExpansion.com or call (865) 238-8304.

Click here to see all recent news from this company

WESTCHESTER, NY–(Marketwire – September 20, 2010) –

WHAT:
Mount Sinai and Westchester Health physicians to conduct a forum about the latest news in prevention and treatment of Breast Cancer and Diabetes. The panel will feature topics such as the new mammogram guidelines, prevention and treatment of breast cancer and fundamentals of diabetes detection and management.

This forum, designed to inform the community and create awareness about Diabetes and Breast Cancer, is FREE, but seating is limited.

RSVP is required. Call: 1 -800-MD-SINAI (800-637-4624) or E-mail: [email protected]

WHEN:
Wednesday, September 22, 2010, 6:00 PM to 8:30 PM

WHERE:
The Mount Kisco Holiday Inn, 1 Holiday Inn Drive, Mount Kisco, NY 10549

WHO:

• Moderated by Nancy R. Beran, MD, Medical Director of Westchester Health
• Diabetes Awareness – Tracy Breen, MD from Mount Sinai and Michael Goldberg, MD of Westchester Health
• Breast Cancer Awareness – Elisa Port, MD from Mount Sinai and Bonnie Litvack, MD, a community imaging specialist in Westchester

ABOUT THE MOUNT SINAI MEDICAL CENTER 
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of a few medical schools embedded in a hospital. It has more than 3,400 faculty members in 32 departments and 15 institutes. The school was awarded for Outstanding Community Service by the Association of American Medical Colleges Spencer Foreman in 2009.

The Mount Sinai Hospital, founded in 1852, is one of the nation’s largest and most-respected voluntary hospitals. In 2009 it was ranked among the nation’s top 20 hospitals. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.

ABOUT WESTCHESTER HEALTH ASSOCIATES
Westchester Health Associates physicians have been caring for patients in Northern Westchester for over thirty years. They have combined community practices to create a unique multi-specialty medical group, with over thirteen different specialties. Westchester Health has over 47 offices located throughout the area which provide personalized attention, as well as confidential and compassionate care. Integrated into each office is direct access to the area’s leading specialists and cutting-edge technology. Westchester Health Associates offers modalities such as electronic medical records, simplified communications between referring physicians, and direct communication with insurance companies.

Many of the Westchester Health physicians have been honored by their peers for their high standards of care, technical expertise, and compassion for their patients. Westchester patients are considered part of the Westchester Health family, which is 100,000 strong and growing.

WINCHESTER, CA–(Marketwire – September 20, 2010) –  Thousands of American men and women have been called to duty, bound for Afghanistan and Iraq since the global War on Terror began, with many having since returned home injured or disabled. For them, the road to recovery can be a long and arduous one. Simple daily activities once accomplished with ease now require planning and effort. Recreational pursuits once enjoyed are now distant memories of a time without disability.

But for some recently injured veterans, sports and activities they once thought were beyond their grasp are now within reach thanks to the Department of Veterans Affairs’ (VA) cutting edge use of adaptive sports medicine and rehabilitation in its third annual National Veterans Summer Sports Clinic.

The Clinic will be held September 19-25 in San Diego, and is aimed at introducing newly injured veterans to adaptive sports. Events include adaptive kayaking, sailing, track & field, cycling and surfing. What makes this rehabilitative event even more successful is that VA includes in the participation of the veterans’ sporting activities spouses or significant others, children and in some cases care givers.

VA is teaming up with founding sponsors Help Hospitalized Veterans (HHV) and the Veterans Canteen Service (VCS) to provide this exciting event along with many other national and community sponsors. The event is hosted by the VA San Diego Health Care System. “VA’s unique approach in ‘treating the whole family’ by including them in Summer Sports Clinic activities demonstrates to the veterans that they can indeed have an active and rewarding leisure lifestyle which their families can enjoy with them. HHV’s mission is to provide products and services that have a therapeutic and rehabilitative benefit to our nation’s hospitalized veterans. Miracles happen here and we are proud to be part of it,” said Mike Lynch, HHV President and CEO.

HHV provides free therapeutic arts & crafts kits to VA and military hospitals worldwide, with over 25 million kits donated since HHV’s inception. For more information about HHV’s programs & services for veteran patients visit www.hhv.org or call 888-567-VETS.

Documents and/or Photos available for this release:

PDF_of_release

To view supporting documents and/or photos, go to www.enr-corp.com/pressroom and enter Release ID: 271023

NEW YORK, NY–(Marketwire – September 20, 2010) – There could be as many as three vaccine treatments for lung cancer by 2015, according to a market research report from Kalorama Information. The report, “Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition,” notes that one product will see an approval in three years and two more products could join shortly thereafter, setting the stage for healthy competition. The healthcare market research publisher recently forecasted a market exceeding $7 billion for vaccines treating all cancers in the next five years. Lung, cervical and prostate cancers are among the most viable areas, according to the report.

Lung cancer continues to be deadly despite a decrease in smoking in many developed countries. Worldwide, more than 1.2 million people are diagnosed with lung cancer annually, while 1.1 million people lose their battle against the disease each year. The American Cancer Society reports that the 5 year survival rate for lung cancer patients in all stages is only 15%.

“Although lung cancer continues to show steadily increasing incidence and mortality rates and is the number one cancer in terms of new cases worldwide, it is still an underserved area of therapeutic options,” said Melissa Elder, analyst for Kalorama Information. “Therapeutic vaccines are a big step in providing life-saving options for these patients.”

According to the report, one of the most promising products in development is Stimuvax, co-developed by Oncothyreon and Merck. The approval of Stimuvax, which Kalorama Information expects to occur in 2013, could slow the number of long-term treatment cases of lung cancer each year, offering huge health and economic benefits to the United States and other approved areas.

Kalorama Information also anticipates the approval of NovaRx Corporation’s Lucanix at the end of 2013, and GlaxoSmithKline’s MAGE-A3 vaccine sometime after 2015 — both products are currently in Phase III development. If approved these products would compete directly with Merck/Oncothyreon’s vaccine, increasing the competitive landscape in the lung cancer treatment segment.

More information on lung cancer vaccine developments can be found in Kalorama Information’s report, “Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition,” which also includes markets for and developments in other cancer areas along with forecasts, issues and company profiles. The report can be found at: http://www.kaloramainformation.com/redirect.asp?progid=79625&productid=2794580.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

TORONTO–(Marketwire – September 20, 2010) –  Patient Prompt, a leader in patient communication technology since 2004, has just completed an in-depth analysis of over a six year period to determine the effectiveness of traditional appointment reminder systems and how advancements in patient communication technology can play an important role in improving patients’ lives and reducing costs for healthcare practices.

Patient Prompt™ analyzed millions of reminder calls on behalf of a variety of group and specialty practices. As a result, new “Best Practice Protocols” were developed. These reminder protocols are specifically tailored to produce the optimum results for the practice.

The result has been a 97% success rate in appointment confirmations with fewer hang ups, reduced patient cancellations, and increased revenue for the practice. Patient Prompt™ “Best Practice Protocols” can play an important role in providing more effective Preventative Care Programs, as well as Patient Compliance Programs.

Patient Prompt™ first revolutionized patient communication in 2004 by introducing its patented “Seamless Two Way Technology™” designed to integrate directly with existing practice scheduling systems to provide real time appointment confirmations. Two years later Patient Prompt™ introduced “Smart Calling Technology™” to reduce the number attempts necessary to reach and confirm patient appointments. 

“Since our inception, our goal has been to provide health care practices with the most effective patient communication tool in the industry. This comprehensive analysis reinforces our belief that traditional automated appointment reminder applications just don’t work. Patient Prompt™ is the culmination of years of research and development. As a long time supporter of the MGMA, we look forward to discussing our findings with its members at the upcoming annual convention in New Orleans in October,” said Jeremy Greven — President & CEO, Patient Prompt™ / Prompt Alert Inc.

About Patient Prompt:

Patient Prompt™ is a product of Prompt Alert Inc. a privately owned technology solution provider specializing in patient communication in the healthcare sector. Established in 2004, Prompt Alert Inc. introduced its highly successful patient communication tool, Patient Prompt™ to service enterprise level practices seeking a customized, flexible, and fully scalable automated patient communication tool. Since its launch, Patient Prompt™ has been the fastest growing patient communication tool in North America, servicing a wide variety of group practices and specialties such as, Cardiology, Gastroenterology, Endoscopy, Orthopedics, Nephrology, and Oncology.

For further information regarding Patient Prompt visit:

www.patientprompt.com or call toll free 1.800.417.9486

ALEXANDRIA, VA–(Marketwire – September 20, 2010) –  As one of Hollywood’s self-proclaimed “fat funny guys,” Anthony Anderson has appeared in comedies including “Big Momma’s House” and “Kangaroo Jack,” but when he was diagnosed with type 2 diabetes at the age of 32, Anderson found that his weight was no laughing matter. In the October issue of Diabetes Forecast, the consumer magazine of the American Diabetes Association, Anderson opens up about incorporating diabetes management into his busy schedule and how his desire to go skydiving has inspired him to shed pounds. 

It was eight years ago that Anderson started experiencing symptoms of diabetes — he was tired and lethargic. “I chalked it up to being overworked,” he tells Diabetes Forecast. “I just thought I was running myself ragged.” When other symptoms started to appear, such as constant thirst and frequent urination, he saw his doctor and was diagnosed with type 2 diabetes. 

After his initial diagnosis, Anderson didn’t make many changes to his lifestyle, only to find that he wasn’t feeling better. The turning point was the idea of skydiving. “I want to skydive,” he says, “and one place I called told me you can’t weigh more than 235 pounds.” At 240 pounds, Anderson asked, jokingly, what he could do. Without missing a beat, the person from the skydiving center said, “Lose five pounds.” He started to run three miles a day, and cut back his portion sizes. “Now I’m well below 235, and I’m going to jump out of a plane!”

Diabetes was not new in Anderson’s family. His father had the disease, and his mother was recently diagnosed. Despite this, Anderson found that there were very few people talking about diabetes who spoke to him as a young African American man. He decided to be a spokesperson for Eli Lilly’s FACE Diabetes, an initiative to educate and empower African Americans about diabetes. “Statistics show that African Americans born today have a 50 percent chance of being diagnosed with type 2 diabetes,” Anderson says. “That’s what I’m doing now with the FACE Diabetes initiative through Lilly — getting as much information [as possible] and bringing awareness to our community and to our youth, because if we catch it early enough, this can be prevented.”

This issue of Diabetes Forecast also features an article titled “Why Me? Understanding the Causes of Diabetes.” It’s the question nearly everyone with a serious illness asks sooner or later: What did I do to deserve this? With both type 1 and type 2 diabetes on the rise, understanding the causes of diabetes may help curb the increase in new cases as well as quiet those pesky questions that have no easy answers.

The October issue offers more:

• Trick or Treat: Enjoying Halloween when you (or your kids) have diabetes
• Healthy Steps: School Walk for Diabetes promotes health and fitness in youngsters
• Research Profile: Can video games help people lose weight? Looking at how the “exergame” Dance Dance Revolution can be used in a diabetes management program

Diabetes Forecast has been America’s leading diabetes magazine for more than 60 years, offering the latest news on diabetes research and treatment to provide information, inspiration, and support to people with diabetes. 

The American Diabetes Association is leading the fight to stop diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure, and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, its mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information, please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

id=”nav_links”>

IRVING, TX–(Marketwire – September 20, 2010) –  Using the clinical improvement methodology outlined in the Leading Practices Portal from VHA Inc., the national health care network, Bassett Medical Center improved its performance on two core measures, pneumococcal vaccination screening and heart failure discharge instructions. During an 18-month period from the first quarter of 2008 through the third quarter of 2009, Bassett’s pneumococcal vaccination screening for patients 65 and older improved to 100% from 72%, an increase of 28%, while its heart failure discharge instructions score improved to 89% from 59%, an increase of 30%.

Bassett Medical center, a 163-bed academic medical center in upstate Cooperstown, N.Y., is a member of the Bassett Healthcare Network.

As the nation’s health care system shifts from a fee-for-service based reimbursement system to a pay-for-performance model, limiting unwarranted or avoidable recurring hospitalizations and preserving quality patient care by using proven clinical processes can positively affect a hospital’s CMS reimbursement. CMS is the Centers for Medicare & Medicaid Services, the U.S. federal agency that administers Medicare, Medicaid and the Children’s Health Insurance Program.

Applying the knowledge from VHA’s Leading Practices Portal, Bassett created interdisciplinary work groups of clinicians who worked collaboratively to implement critical practice changes that led to the organization’s success. For example, the health system had traditionally administered the pneumonia vaccine to patients upon discharge. Supported by evidence from VHA’s Leading Practice Blueprint™ packet, internal consensus suggested administering the vaccination upon a patient’s admission.

VHA’s efforts to help members improve clinical performance align with its larger efforts to help them prepare for Medicare’s value-based purchasing program, which officially begins in October 2012, but baseline performance is being measured now. The second component of VHA’s VPB work involves helping members with their patient experience scores.

“Transferring knowledge from the blueprints involved applying social science techniques that enabled us to see both sides of clinical improvement,” said Kathleen Reilly, director of Quality Management at Bassett Medical Center. “Looking beyond the empirical data to understand the context of our own health system allowed us to implement the improvement measures successfully within our own environment.”

For more information on how VHA is helping hospitals improve clinical performance, go to https://www.vha.com/Solutions/ClinicalImprovement/Pages/Default.aspx

About VHA — VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. In 2009, VHA delivered record savings and value of $1.47 billion to members. Formed in 1977, through its 16 regional offices, VHA serves 1,400 hospitals and more than 30,000 non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

About Bassett Medical Center: Bassett Healthcare Networks is an integrated health care system that provides care and services to people living in an eight county region covering 5,600 square miles in update New York. Bassett Medical Center, the foundation for the Bassett Healthcare Network, is a 180-bed, acute care inpatient facility that maintains a strong academic program through its affiliation with Columbia-Presbyterian Medical Center. The Bassett Clinic provides outpatient primary and specialty care. Bassett offers 24-hour emergency and trauma care, comprehensive cancer care and heart care, dialysis and most medical and surgical specialties in Cooperstown.

TUCSON, AZ–(Marketwire – September 20, 2010) –  Travel + Leisure has revealed its Top Ten Destination Spas (World’s Best Awards 2010) and Canyon Ranch is thrilled to announce it has received this highly coveted accolade. Resort properties in Tucson and Lenox are once again joining the ranks, and Canyon Ranch Hotel & Spa in Miami Beach is making its debut.

The “World’s Best Awards” are voted on by the readers of Travel + Leisure to honor the top hotels, destinations, airlines, cruises, spas and transportation companies in the world. In the annual survey, destination spas were rated independently by Travel + Leisure readers in five categories: accommodations/ambiance, treatments, service, food and value. The Top Ten Destination Spas will be featured in the October issue of Travel + Leisure magazine (on newsstands September 24) and on www.travelandleisure.com.

“We couldn’t be happier to see three of our properties listed in the World’s Best Awards by the well-traveled readers of Travel + Leisure,” said Jerry Cohen, Canyon Ranch Vice Chair and CEO. “This recognition reflects our continued dedication to creating an environment that promotes health and the highest enjoyment of life for all of our guests.”

As a newcomer to the list, Canyon Ranch Hotel & Spa in Miami Beach, which opened in November 2008, has quickly established itself as a top hotel for the healthful minded traveler. Canyon Ranch Hotel & Spa in Miami Beach provides its guests with an integrative approach to health and wellness in order to create a life-enhancing transformation while also delivering a complete luxurious travel experience and world class spa.

“Canyon Ranch was founded 31 years ago with a mission to inspire people to make a commitment to healthy living,” said Cohen. “Whether our guests choose to experience Canyon Ranch in Tucson, Lenox or Miami Beach, they know they will receive the same personalized attention — it’s the Canyon Ranch way of life.”

About Canyon Ranch
Canyon Ranch pioneered the evolution of wellness lifestyle and has been an industry leader for 30 years. Operating the world’s most celebrated collection of life-enhancement properties, Canyon Ranch has destination health resorts in Tucson, Ariz., Lenox Mass., and recently opened Canyon Ranch Hotel & Spa in Miami Beach, the nation’s first luxury wellness hotel and residential community. In addition, Canyon Ranch operates SpaClub facilities (spa, wellness and fitness facilities designed to give guests a taste of the more intensive resort experiences) at The Venetian & The Palazzo in Las Vegas, Nev. and the newest Canyon Ranch venture, Canyon Ranch SpaClub at Sea, features facilities onboard ships that make up Oceania Cruises and Regent Seven Seas Cruises, as well as on board Cunards’ Queen Mary 2 luxury ocean liner. In addition, the company Canyon Ranch has been named the “Healthiest Spa in America” by Health magazine as well as the “Best Spa for Food” by Gourmet magazine. Also, Canyon Ranch is the only 11-time recipient of the Condé Nast Traveler Best Destination Spa Award.

Click here to see all recent news from this company

SECAUCUS, NJ and ST. LOUIS, MO–(Marketwire – September 20, 2010) –  Panasonic Solutions Company, manufacturer of durable, reliable Panasonic Toughbook® mobile solutions for government and commercial enterprises, and Mobile Armor, Inc., a leader in portable data encryption and mobile device management, today announced the companies have entered into a license and reseller agreement to integrate the Mobile Armor Data Encryption Solution into select Panasonic Toughbook rugged notebooks and mobile clinical assistants (MCA).

Mobile Armor’s DriveArmor is an enterprise-class solution for policy-driven control for managing data security on notebook PCs and desktop computers with FIPS certified 2.5-inch self-encrypting disk drives from Seagate Technology®. DriveArmor delivers centralized management, strong pre-boot authentication and extensive auditing and reporting capabilities for Seagate® Momentus® self-encrypting drives, designed to prevent unauthorized access to data on lost or stolen computers. Seagate Momentus self-encrypting drives and Mobile Armor DriveArmor ship fully integrated and are available today on the Toughbook 31 flagship rugged clamshell, the Toughbook 19 rugged convertible tablet and the Toughbook H1 Health, a mobile clinical assistant device developed for healthcare users.

“In regulated sectors like the federal government, law enforcement and healthcare, customers often require FIPS 140-2 Level 2 encryption certification,” said Roger Kay, president, Endpoint Technology Associates. “This relationship will deliver integrated multi-layer data protection to Toughbook PC users right out of the Panasonic factory.”

“Customers in classified environments depend on the physical security of Panasonic Toughbook mobile computing devices. Combining our best-in-class rugged computing features, Seagate Momentus self-encrypting hard drives and Mobile Armor DriveArmor award winning management and authentication create a secure computing choice for these mission-critical users,” said Jan Ruderman, vice president, government solutions, Panasonic Solutions Company.

DriveArmor is just one product in Mobile Armor’s arsenal of fortified data encryption and device management products. Mobile Armor is the only vendor to offer a fully integrated, centrally managed data encryption suite that protects mobile and desktop PCs, smartphones, CD/DVDs, removable media and ships FIPS certified 140-2 level 3 USB encrypted flash drives with embedded anti-virus protection. The Mobile Armor Suite may be delivered on-premise or in a SaaS hosted environment.

Mobile Armor also announced that Panasonic is an Authorized Reseller of the complete Mobile Armor Data Encryption Suite: PolicyServer™, DataArmor™, FileArmor™, KeyArmor™ and DriveArmor™.

“We are excited to create such an all-encompassing relationship with Panasonic, incorporating product development and integration, sales and marketing and technical support,” said Michael Menegay, Mobile Armor’s chief executive officer. “Toughbook customers have come to expect superior computing products from Panasonic and Mobile Armor customers expect the same superior quality for data protection. Jointly we are providing industry-leading hardware and software that is at the forefront of innovation resulting in the most reliable solutions in response to the current security climate and regulatory compliance mandates.”

About Panasonic Solutions Company
Panasonic Solutions Company empowers people whose jobs depend on reliable technology. The company delivers collaboration, information-sharing and decision-support solutions for customers in government, healthcare, education and a wide variety of commercial enterprises. Products and services within the company’s portfolio include Panasonic Toughbook® mobile computing solutions, projectors, professional displays (including both plasma and LCD), and HD and 3D video acquisition and production solutions. As a result of its commitment to R&D, manufacturing and quality control, Panasonic is known for the reliability and longevity of its products. Panasonic Solutions Company is a Division of Panasonic Corporation of North America, which is the principal North American subsidiary of Panasonic Corporation (NYSE: PC).

Information on Panasonic Solutions Company’s full line of products can be obtained by calling 877-803-8492 or at www.panasonic.com/business-solutions.

About Mobile Armor
 Mobile Armor, Inc. is an innovator and a visionary leader in data protection and encryption technology, headquartered in St Louis, Missouri. Mobile Armor is an American company that provides domestically developed trusted data security solutions to commercial and government organizations. Notable customers include the U.S. Army, U.S. Navy, civilian agencies and customers in healthcare and financial services verticals. Mobile Armor offers a solution that provides centralized management of all mobile devices, including desktops, laptops, PDAs, smartphones, and removable drives (including thumb drives). The company is a recipient of the coveted DoD Data at Rest Tiger Team award for its data encryption products. Mobile Armor technology is certified to meet the standards and guidelines for security set by the National Institute of Standards and Technology (NIST). Additional information regarding Mobile Armor can be found at www.mobilearmor.com.

About Seagate
Seagate is the worldwide leader in hard disk drives and storage solutions. Learn more at http://www.seagate.com. Seagate, Seagate Technology and Momentus are registered trademarks of Seagate Technology LLC or one of its affiliated companies in the United States and/or other countries.

All brand and company/product names are trademarks or registered trademarks of the respective companies. All specifications are subject to change without notice.

id=”nav_links”>

MISSION, KS–(Marketwire – September 20, 2010) –  (Family Features) If you’re the parent of a teen or tween, chances are you’ve wondered, half-jokingly, if your child hears anything you say. The reality is that there are over 6.5 million American children ages 12 to 19 living with some form of hearing loss — and much of it is preventable.

Noise induced hearing loss
Every day, we experience sound in our environment — from television and radio, to household appliances and dreaded rush-hour traffic. Normally, we hear these sounds at safe levels that do not affect our hearing. However, when we are exposed to harmful noise, sounds that are too loud or loud sounds that last a long time, sensitive structures in our inner ear can be damaged, resulting in noise induced hearing loss (NIHL).

Noise induced hearing loss can be caused by a one-time exposure to an intense “impulse” sound, such as an explosion, or by continuous exposure to loud sounds over an extended period of time, such as a too-loud MP3 player. According to the National Institute of Health (NIH), long-term exposure to 80 to 85 decibels, or any more than 15 minutes exposure to 100 decibels, can lead to hearing loss. Music players like iPods can top 100 decibels when turned all the way up.

In fact, according to a survey conducted by Hear the World, a global initiative by leading hearing system manufacturer Phonak, exposure to high noise levels was found to not only result in gradual hearing loss, but also stress, aggression or insomnia in 73 percent of those surveyed.

MP3 players and your teen

A study released in the Journal of the American Medical Association found that 1 in 5 U.S. teens suffer from some form of hearing loss. Among other culprits named, from nutrition to environmental toxins, the use of the “earbud” style of headphones while listening to high decibel music was found to be one reason for the increase.

“It is no surprise that teens and young adults today are listening to music longer and potentially louder than years past,” said Dr. Craig Kasper, Chief Audiology Officer of Audio Help Hearing Centers and Hear the World spokesperson. “Ongoing exposure to loud sounds daily, through earphones for example, can have a direct impact on your hearing early in life and not just as you age.”

How loud is too loud? If an earbud headphone sounds loud to people nearby, it’s too loud.

If you suspect your child might have hearing loss, contact your local audiologist for a complete hearing screening. For more information on hearing loss and how loud is too loud, as well as an online hearing test, visit www.hear-the-world.com.

Reducing the risk
The good news is that noise induced hearing loss is 100 percent preventable.

“The impact of noise on hearing is often underestimated because the damage may take place gradually. As a result, many people do little to prevent the process of hearing loss that takes place throughout their lives due to the noise pollution around them,” said Dr. Kasper.

To protect hearing, Dr. Kasper recommends these tips for teens and tweens:

1. Be mindful of your hearing. Think about the level of noise you’re exposed to as well as the duration of time you’re in that noise.
2. When attending concerts or loud events, wear hearing protection. Most of us would never think to sunbathe without some form of SPF protection. Using either over-the-counter earplugs or custom-molded hearing protection is like SPF for your ears.
3. When listening to your iPod or other MP3 player, invest in a sound-isolating earphone, such as the Audéo PFE by Phonak (see sidebar). This will reduce the amount of environmental sounds and allow you to turn the volume down.

Sound waves travel through the ear canal to the inner ear, where tiny hair cells convert the sound into nerve impulses that travel to hearing centers in the brain. Excessive noise can damage those cells and cause permanent hearing loss.

Top five misconceptions about hearing loss
1. Hearing loss is only for the elderly: Only 35 percent of people with hearing loss are older than age 64. There are over 6.5 million American children ages 12 to 19 living with some form of hearing loss.
2. If my child or I had hearing loss, my family doctor would have told me: Only 14 percent of physicians routinely screen for hearing loss during a physical.
3. Your hearing loss cannot be helped: With modern advances in technology, nearly 95 percent of people with a sensorineural hearing loss — a type of hearing loss in which the root cause lies in the inner ear — can be helped with hearing aids.
4. Hearing aids are large, clunky and obvious: Many modern hearing aids are nearly invisible to the naked eye and smaller than a quarter.
5. Hearing loss isn’t serious enough to treat: Hearing loss can create social and emotional barriers for the individuals living with it, or the families of those it affects. Research shows that when left untreated, hearing loss can lead to reduced earning power, disruptions in family life and can cause a wide range of other psychological problems.

Signs of hearing loss in your teen

• Loss of hearing sensitivity, first to high-pitched (high-frequency) sounds, then eventually to lower pitches.
• Difficulty hearing conversations, especially in a group setting or in a noisy environment.
• Temporary or permanent ringing, buzzing or fluttering in one or both ears.
• Often asks people to repeat themselves.
• Needs to set the TV or radio volume louder than other people.
• A sense of fullness in the ears.
• Voices and other noises sound muffled and/or distorted.

Audéo PFE Perfect Bass
The Audéo PFE (Perfect Fit Earphones) Perfect Bass are a set of high-end, sound-isolating earphones by leading hearing systems manufacturer Phonak. The Audéo PFE provides exceptional fit with different, replaceable ear tips, great sound (even at low volume levels) without sacrificing the health of your ears, and starts below $100. The Audéo PFE Perfect Bass can be purchased online at www.audeoworld.com.

BIRMINGHAM, UNITED KINGDOM–(Marketwire – Sept. 20, 2010) – If you think hair loss is a condition which only affects men when they hit their 50s, think again, as more than a third of 25 to 35-year-old females suffer from the devastating condition.

There are a number of reasons why premature hair loss is now increasingly common in women, including crash dieting, low iron levels, hormone changes post-pregnancy and certain medications.

Genes also play a part, with the likelihood of bald patches increasing if a woman’s mother also has thin hair and for many, it can have a profound effect.

Leading psychologist Dr Linda Papadopoulos said: “In our culture, hair is bound up in notions of womanhood and sexual attractiveness. Plus, we live in such an appearance-driven society that our looks often become one of the largest factors contributing to our self-esteem”

We all naturally lose between 50 to 100 strands of hair a day, but how can you know when you are losing too much?

The simplest way to judge excess shedding is if you see more hairs than usual falling on a daily basis – over a period of at least a month. Often a change of diet can restore hair back to its former glory, but don’t despair, if eating well still doesn’t help, there are a number of cutting edge treatments available at The Hospital Group.

The Hospital Group carry out more hair transplant procedures than anyone else in the UK, using the very latest Follicular Unit Techniques and non-surgical therapies. 

Leading hair transplant surgeon, Dr Peter Williams from The Hospital Group said: “For both women and men the loss of hair can be a very emotional experience but The Hospital Group can provide expert advice with experienced hair transplant surgeons.

“Hair transplants are becoming increasingly popular and the techniques used have advanced substantially. At The Hospital Group only state-of-the-art techniques are used to achieve the best possible results and men and women are now keen to benefit from the amazing results of hair restoration that are on offer.”

Providing expert advice and assistance, The Hospital Group carries out more hair transplantations than any other clinic in the UK, recognising that hair restoration is an art just as much as a surgical procedure.

Since The Hospital Group was established in 1992, it has grown from a small pharmaceutical company to one of the UK’s foremost weight loss surgery and cosmetic surgery providers.

For further information of The Hospital Group’s range of surgical procedures, surgery-seekers should visit the website www.thehospitalgroup.org or call our patient care coordinators on 0845 762 6727.

POMONA, CA–(Marketwire – September 17, 2010) –  Renowned author Ray Bradbury will make a special appearance at Western University of Health Sciences on Friday, Oct. 8, 2010 as part of Pomona’s “Fahrenheit 451” Big Read.

Ray Bradbury and Sam Weller, his authorized biographer, will appear at WesternU’s Health Education Center, 701 E. Second St., Pomona, Calif., from 6 to 9 p.m. Oct. 8 to discuss “The Bradbury Chronicles” and the newly released “Listen to the Echoes: The Ray Bradbury Interviews.”

“An Evening with Ray Bradbury and Sam Weller” will feature an interactive program with the two men, and is a rare opportunity to meet one of America’s most celebrated authors. A reception will be held at 6 p.m., with a book signing following the program.

Bradbury will sign copies of “Fahrenheit 451,” and Weller will sign copies of “The Bradbury Chronicles” and “Listen to the Echoes: The Ray Bradbury Interviews.” No other books, CDs, DVDs or memorabilia of any kind, please.

This event, which is open to the public, serves as the kick-off for Pomona’s “Fahrenheit 451” Big Read. Everyone in the community is invited to read the novel “Fahrenheit 451” and share in the numerous discussions, film screenings, art exhibits and other events scheduled throughout October and November. Event details and updates are available on the Pomona Public Library web page (www.pomonalibrary.org) and here (http://www.neabigread.org/communities/?community_id=2024), or call the Pomona Public Library at 909-620-2043.

The goal of the Big Read is to restore reading to the center of American culture and highlight the importance of literature in daily life. The Big Read, a program of the National Endowment for the Arts, aims to directly address the decline of reading for pleasure by providing citizens with an opportunity to read and discuss a single book within their community.

WesternU’s Harriet K. and Philip Pumerantz Library, 287 E. Third St., Pomona, will feature a special display of controversial medical books and some consumer health books that have been banned, as well as “Fahrenheit 451” and other fiction. The “Banned Books Display” will remind students and visitors not to take freedom for granted. The display runs Sept. 25 to Oct. 31, 2010.

NEW YORK, NY–(Marketwire – September 17, 2010) – Save the Children experts attending the summit can discuss the following and more:

• How the MDGs affect everybody–even those who’ve never heard of them.
• What’s happening on the ground in the race to achieve the MDGs by 2015.
• How the MDGs have been incredibly successful in some of the poorest countries on earth–and what’s preventing them from being achieved elsewhere.
• Why U.N. Secretary General Ban Ki­moon will ask the world to focus on MDGs 4 and 5 (reducing child and maternal mortality), and what that’s likely to achieve.
• How the launch of a new nutrition movement could save 2.7 million children a year.
• How the U.S. role in global development could change in the years to come.

Charles MacCormack, President and CEO of Save the Children USA
Dr. Charles MacCormack is a senior statesman among leaders of U.S. development and humanitarian organizations. He has been president of Save the Children USA since 1993 and joined its board in 1989. Save the Children is the leading independent organization for children in need, with programs in 120 countries, including the United States. The agency works for immediate and lasting change in children’s lives by improving their health, education and economic opportunities. In times of acute crisis, Save the Children mobilizes rapid assistance to help children recover from the effects of war, conflict and natural disasters.

Anne M. Mulcahy, Chairman of the Board of Trustees, Save the Children USA; Former Chairman and CEO, Xerox Corporation
Anne Mulcahy saved Xerox and now she’s saving children. She became Chairman of Save the Children in March, 2010, after retiring as CEO of Xerox. One of the few women to lead a Fortune 500 company, she executed a dramatic turnaround at Xerox, lifting the corporation from threat of bankruptcy and putting it back on a profitable path. She’s recently visited Save the Children programs in Haiti, Guatemala and Afghanistan.

Ambassador Michael Klosson, VP for Policy and Humanitarian Response, Save the Children USA
Ambassador Michael Klosson draws on decades as a U.S. diplomat to advocate for children. He oversees Save the Children’s public policy and advocacy work with the U.S. and foreign governments around issues including health, education, food security, emergencies, and aid effectiveness. He also leads Save the Children’s emergency response work, including in Pakistan and Haiti.

Mary Beth Powers, Chief, Newborn & Child Survival Campaign, Save the Children USA
 Mary Beth Powers leads a campaign to bring lifesaving care to children in need. Save the Children’s “Seewherethegood goes™” campaign mobilizes citizen action to help local health workers help save more children worldwide. Powers is passionate about the power of training people in their own communities to provide better health opportunities for newborns and children around the world. See videos and blogs from these frontline workers at GoodGoes.org.

Carolyn Miles, Executive Vice President and Chief Operating Officer, Save the Children USA
Carolyn Miles manages all aspects of the global operations of Save the Children USA. She recently returned from Pakistan, where Save the Children has a major humanitarian response to the floods. Other recent trips to the field include Bangladesh and Haiti. Before joining Save the Children in 1998, she was an executive at American Express and a successful private entrepreneur in Hong Kong.

Dr. Rajiv Tandon, Sr. Advisor, Maternal, Newborn, Child Health and Nutrition, Save the Children India
Dr. Tandon works to save children’s lives in India, where more die than anywhere else. One fifth of the 8.1 million newborns and children who die before age 5 each year live in India. Most of those 1.7 million children die from preventable causes. Dr. Tandon is a pediatrician and public health expert with 25 years experience in child health and nutrition.

id=”nav_links”>

DALLAS, TX–(Marketwire – September 17, 2010) –  RxAir™ Industries, LLC (RxAir™), a leading manufacturer of patented air purification and isolation systems and accessories for medical and hospitality facilities nationwide, announced today that Global Protection will be showcasing RxAir’s products at the Disaster Planning for California Hospitals Conference in Sacramento, CA, September 21^st – 23^rd, 2010 at the Sacramento Convention Center and Hyatt Regency in Booths 62 & 63 http://www.calhospital.org/disasterplanning. The conference is organized by the California Hospital Association (CHA) http://www.calhospital.org/, which collaborates with its members to provide strong and effective representation and advocacy to advance the interests of California hospitals, patients and communities.

Global Protection is a proud distributor of RxAir’s products. Global Protection’s sales force will be available at the conference to discuss the features and benefits as well as answer questions about RxAir’s products. To set up a private one-on-one meeting to learn more about how RxAir’s products can benefit your hospital, please contact Jack Denker, Dir. of Sales for Global Protection, at [email protected].

About RxAir™ Industries, LLC
RxAir Industries, LLC (RxAir™) is a leading manufacturer of patented air purification systems and accessories for medical and hospitality facilities nationwide. The Company’s patented technologies originated more than 15 years ago through a partnership with Baylor Biomedical Services in Dallas, TX. RxAir™ air purification systems utilize HEPA filtration technologies enabling the filtration of air at high levels of efficiency, exceeding 99.97%, comply with NIOSH & CDC recommendations and are certified to UL electrical safety standards. RxAir™ air purification systems are manufactured in the USA. For more information about RxAir™ air purification systems and accessories please visit http://www.rxair.com.

About Global Protection
Global Protection offers Preparedness products which include: Protective Suits, Gas Masks, Air Purification and a variety of equipment used for protection against Domestic Emergencies. US government agencies, Police and Fire First responders, HealthCare companies, and individuals rely on Global to provide the leading products to protect against potential pandemics, chemical warfare agents, biological warfare, and terrorist threats such as Anthrax, Smallpox, and Nerve Gas. For more information please visit http://www.globalprotectionllc.com.

Click here to see all recent news from this company

LAS VEGAS, NV–(Marketwire – September 17, 2010) – Medex, Inc. (PINKSHEETS: MDXX) today announced that on September 27, 2010 the Company will issue updated financials reflecting the closing of the previously announced Creative Rehab Technology Services, Inc. and Bee Mobile, Inc. acquisitions. Audited figures are expected to be consistent with previously disclosed revenue and earnings estimates and include those for the previously announced second Bee Mobile location which is now in operation.

In a related disclosure, Medex indicated that as of the close of the Company’s fourth quarter, December 31, 2010, Medex will commence routine scheduled quarterly earnings releases and investor conference calls. 

“Transparency is the foundation of investor confidence for any publicly held concern. As Medex energes from concept to reality and now perpares to accelerate its acquisition activity, routine financial disclosure is essential,” said Paul Protzman, President of Medex, Inc. “With newly acquired and growing revenue as well as free cash flow, the timing is now appropiate to begin this activity.”

About Medex, Inc.

Medex, Inc. is a development stage Nevada-based medical support services company, which plans to grow through acquisitions of medical supply companies, medical technology companies, and assisted living and care facilities worldwide. For additional information, see www.medexsynergies.com.  

Safe Harbor Statement:

This release contains “forward-looking statement” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

TAMPA, FL–(Marketwire – September 16, 2010) –  Sage North America today announced that the Sage Healthcare Division, a provider of electronic health records (EHR) and practice management software, has launched its Customer Appreciation Program (CAP) that’s designed to say thank you to its existing customers and provide them with assistance toward adopting EHRs and achieving meaningful use requirements. Under this loyalty program, qualifying Sage customers can receive additional software to help them achieve federal stimulus incentives, manage care quality and evolve with the changes in healthcare today.

“For customers who have been part of the Sage Healthcare family, the Sage Customer Appreciation Program shows that not only do we appreciate their loyalty and commitment, but that we are invested in their success and want them to achieve their goals,” said Tony Ryzinski, Senior Vice President of Marketing at Sage Healthcare. “Many of our customers are asking how to achieve meaningful use compliance and benefit from stimulus funding. The Sage Customer Appreciation Program will help by reducing barriers practices face as they continue making investments in their business.”

Sage created the CAP to honor the commitment their customers have demonstrated by supporting Sage and its solutions over the years. More than a resource to help eligible Sage clients reach EHR and meaningful use, Sage considers CAP a rewards-style program.

Sage customers have the benefit of choice. Based on customer feedback, many practices would prefer to stay on the practice management system, such as Sage Medical Manager, they’ve used and trusted for years while they focus on implementing an EHR. Others are ready to make a bigger change and take advantage of the full Sage Intergy product family. Sage Intergy EHR and the Sage Intergy Meaningful Use Edition allow customers to select the best path for their practices.

“Navigating the complexities of the ever changing healthcare economy has been a major source of anxiety for many customers,” said Ryzinski. “Sage is committed to helping our customers evolve with these changes, meet upcoming regulatory requirements such as 5010 and ICD-10 as well as achieve meaningful use — all of which equate to better patient health care outcomes, which is always our ultimate goal.”

View Sage Healthcare Division YouTube interviews.
View Sage Healthcare Division information.

About Sage Healthcare Division
Sage Healthcare Division provides integrated electronic health records, EDI applications and practice management systems to approximately 80,000 physicians and thousands of ambulatory care practices throughout North America. These systems enable physicians and practice managers to better manage their practices and improve profitability. Sage Healthcare Division is based in Tampa, Fla., and is a division of Sage North America. For more information, please visit www.sagehealth.com or call (877) 932-6301.

About Sage North America
Sage North America is part of The Sage Group plc, a leading global supplier of business management software and services. Sage North America employs 4,000 people and supports 3.1 million small and midsized business customers including approximately 80,000 physicians. The Sage Group plc, formed in 1981, was floated on the London Stock Exchange in 1989 and now employs 13,100 people and supports 6.2 million customers worldwide. For more information, please visit the website at www.sagenorthamerica.com.

© 2010 Sage Software, Inc. All rights reserved. Sage, the Sage logos, and the Sage product and service names mentioned herein are registered trademarks or trademarks of Sage Software, Inc. or its affiliated entities. All other trademarks are the property of their respective owners.

NORTHFIELD, IL–(Marketwire – September 16, 2010) – 50 million Americans live in rural areas, and accessing healthcare when they need it can be challenging and costly. Complicating matters is that individuals living in these areas have a higher prevalence of chronic health conditions, such as heart failure and chronic obstructive pulmonary disease (COPD).

To combat this challenge, Pharos Innovations, the provider of unique IVR and Web-based remote patient monitoring/behavior change technology, has partnered with South Jersey Healthcare (SJH)-a leading regional healthcare provider in southern New Jersey that serves a largely rural and hard to reach population — to improve access to care and care quality for patients with heart failure. Pharos and SJH today announced that, due to the program’s success, they are expanding the Tel-Assurance program to include the monitoring and management of patients with COPD.

Through the current heart failure program, SJH reduced hospital admissions by 60% for enrolled patients, reduced healthcare costs for the enrolled population by $1,203 per patient and achieved an 83% patient satisfaction rate — proving that a technology-leveraged chronic care management program can penetrate diverse geographies, including low socioeconomic groups, to improve access to care and quality of life and reduce healthcare costs.

“We have seen first-hand the impact that regular monitoring and management through Tel-Assurance can have on patients with heart failure, especially those who live in rural areas, and on improving outcomes and organizational performance,” said Dr. Steve Linn, Chief Medical Officer, South Jersey Healthcare. “We are expanding our partnership to afford our patients with COPD the same benefits and see an even greater reduction in avoidable hospital readmissions.

“One of the great values of Tel-Assurance is that it consistently and sustainably reduces average length of stays and readmissions; improves care access and quality and improves patient and care manager satisfaction for a multitude of chronic and costly conditions across various geographies and demographics,” said Randall E. Williams, CEO, Pharos Innovations. “We designed Tel-Assurance to reach even the most challenging populations and easily scale.”

About South Jersey Healthcare
SJH is a nonprofit, integrated health care system, providing access to a continuum of health services. SJH provides hospital services, numerous community health clinics, home health services, and specialty services, which serve the medical and health care needs of Southern New Jersey residents.

About Pharos Innovations
Pharos Innovations is actively involved in transforming the U.S. healthcare delivery system. Pharos offers IVR and Web-based behavior change services and tools that enable payers and providers to cost-effectively and efficiently manage their chronic care population.

Pharos’ main offering, Tel-Assurance, engages, motivates and drives improved self-care. Through Tel-Assurance, participants self-report their health status daily through the phone or Web. This unique approach actively engages individuals with chronic conditions in their healthcare and provides care managers/nurses with real-time information to intervene before symptoms escalate. Tel-Assurance has been proven an effective way to reduce avoidable, all-cause hospital admissions and readmissions and reduce overall healthcare costs among diverse populations.

The Pharos’ solution is strongly validated to show measured clinical improvement and financial impact, is the recipient of the prestigious American Heart Association National Outcomes award and was selected for the first ever National Institutes of Health (NIH) sponsored evaluation of remote monitoring interventions. For more information visit www.pharosinnovations.com or join in on the discussion at our blog, www.thecollaborativeforum.com.

id=”nav_links”>

WAYNE, PA–(Marketwire – September 16, 2010) –  Clinical and Laboratory Standards Institute (CLSI) recently published a document, “Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline — Second Edition” (M45-A2). This document provides guidance to clinical or public health microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI documents “Performance Standards for Antimicrobial Disk Susceptibility Tests” (M02) or “Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically“ (M07).

Franklin R. Cockerill, III, MD, Mayo Clinic College of Medicine, and chairholder of the Subcommittee on Antimicrobial Susceptibility Testing, says, “This important document compiles a number of guidelines for antimicrobial testing of fastidious or rarely encountered bacteria that cause human disease. Because no other document like this has existed, it fills a significant void in laboratory practice that has existed for many years.”

James H. Jorgensen, PhD, The University of Texas Health Science Center, and chairholder of the working group that developed the guideline, explains, “This second edition of the guideline includes several organisms and groups previously included in the main CLSI M100 supplement tables published each year. In the future, those less common or fastidious organisms will be found only in M45. This document provides the microbiologist with expert advice regarding when and how to test organisms that may only be recovered from certain patients or on an infrequent basis. This update allows us to include the revised cephalosporin interpretive breakpoints from the Enterobacteriaceae from M100 for testing and reporting with Aeromonas and Vibrio species.”

The tabular information in the document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in the guideline.

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information, visit the CLSI website at www.clsi.org or call 610.688.0100.

Click here to see all recent news from this company

SAN FRANCISCO, CA–(Marketwire – September 16, 2010) – Medizone International, Inc. (OTCBB: MZEI) (OTCQB: MZEI) announced today it has filed a US Provisional patent application covering the use of AsepticSure™ for disinfecting sports equipment and training facilities.

Dr. Michael Shannon, Medizone’s Director of Medical Affairs, commented, “The CDC estimates that 100,000 people a year die from MRSA (staph infections). The CDC estimates 20% of hospital acquired MRSA infections cause death. Unfortunately, a new variant of MRSA is emerging within the broader community which has a much higher fatality rate, by some estimates reaching 50%. This newer variant is now being discovered in sports training facilities including those associated with professional, college and high school level teams. Recent investigations have revealed a broad range of bacteria at high concentration actually residing within unclean sports equipment which tend to be covered in mucus, sweat, dead skin and occasionally blood; ideal culture media for bacteria, fungi and mold. There have been a number of recent cases in which the use of contaminated sports equipment has lead to infections so severe that players, children in particular, have become critically ill from the resulting sepsis. So we believe that there is an obvious public health need to be addressed with AsepticSure™. Our technology is safe and we now have hard data to substantiate our claim of high efficacy in dealing with this growing community problem.”

Medizone’s CEO, Edwin Marshall, stated, “Our researchers have identified nuances in addressing the disinfection of sports equipment that again allows us to increase the patent protection wall being built around our AsepticSure™ sterilization system. We believe all of our recently filed additional patent applications, both US applications and international applications, will prove to greatly enhance the commercial value of our technology.”

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures with additional variants for sports facilities and food processing applications.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Click here to see all recent news from this company

SOPHIA ANTIPOLIS, FRANCE–(Marketwire – September 15, 2010) – Partners to exploit new approach
to the delivery of nitric oxide

www.nicox.com

NicOx S.A. (NYSE Euronext Paris: COX) today announced that it has agreed
with its partner Merck, known as MSD outside the United States and Canada,
to expand the scope of their worldwide license agreement, originally
executed in 2006. This decision follows the discovery of a new approach to
nitric oxide (NO) donation during the course of the joint research program.

This approach may be used to develop new classes of NO-donating new
molecular entities (NMEs), designed to offer a different mechanism for
controlling the delivery of NO while retaining the potential therapeutic
benefits. Additional information will not be disclosed for reasons of
commercial confidentiality.

The clinical program evaluating several NO-donating antihypertensive
candidates from the original agreement in healthy volunteers and mild to
moderate hypertensive patients has now been completed and none of the
compounds tested will be further advanced in development.

NicOx has developed a world-leading position in the therapeutic application
of NO-donating compounds. NO is an endogenous cell-signaling molecule of
basic importance in physiology and there is significant evidence that
certain diseases are related to a deficiency in the production of nitric
oxide. This new approach with Merck continues to build on the concept of a
slow release of NO with a sustained pharmacological effect at tissue level.

Under the revised agreement, Merck has the right to develop NMEs using this
new approach in certain cardiovascular indications. NicOx will have the
right to develop product candidates in other indications. NicOx and Merck
will pay development milestones and royalties to the other partner on
products emerging from their respective research programs. NicOx and Merck
have agreed that no further announcements on the compounds developed by
Merck under the collaboration are anticipated unless and until a drug-
candidate advances into phase 2 clinical studies.

Ennio Ongini, Vice President Research at NicOx, commented: “The research
collaboration with Merck has been very fruitful, and it is as a result of
the excellent scientific interaction that this new approach to NO donation
was discovered. Novel molecules using this approach offer an exciting new
alternative route to exploit the biological properties of NO which can
potentially be used in a wide range of therapeutic areas.”

Under the revised agreement, each company will be responsible for funding
their own research and development costs. NicOx and Merck do not have the
option to co-promote any NMEs from the other partner resulting from this
expanded license.

Risks factors which are likely to have a material effect on NicOx’s
business are presented in the 4th chapter of the ” Document de
référence, rapport financier annuel et rapport de gestion 2009 ”
filed with the French Autorité des Marchés Financiers (AMF) on
March 5, 2010 and available on NicOx’s website (www.nicox.com) and on the
AMF’s website (www.amf-france.org).

The Company notably draws the investors’ attention to the following risk
factors:

– Risques liés à la dépendance de la Société
à l’égard du naproxcinod (Risks related to the Company’s
dependence on the success of its lead product naproxcinod)

– Risques commerciaux et développements cliniques (Clinical
developments and commercial risk)

– Risques liés aux contraintes réglementaires et à la
lenteur des procédures d’approbation (Risks linked to regulatory
constraints and slow approval procedures)

– Manque de capacités dans les domaines de la vente et du marketing
(Lack of sales and marketing capabilities)

– Incertitude relative aux prix des médicaments et aux régimes de
remboursement, ainsi qu’en matière de réforme des régimes
d’assurance maladie (Uncertainty on drug pricing and reimbursement policies
and on the reforms of the health insurance systems)

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a pharmaceutical company
focused on the research, development and future commercialization of drug
candidates. NicOx is applying its proprietary nitric oxide-donating R&D
platform to develop an internal portfolio of New Molecular Entities (NME)
for the potential treatment of inflammatory, cardio-metabolic and
ophthalmological diseases.

NicOx’s lead investigational compound is naproxcinod, an NME and a first-
in-class CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-
inflammatory drug candidate developed for the relief of the signs and
symptoms of osteoarthritis (OA). In July 2010, the FDA provided a Complete
Response Letter to the New Drug Application (NDA) for naproxcinod stating
that it does not approve the naproxcinod application. The naproxcinod
Marketing Authorization Application (MAA) submitted by NicOx in December
2009 is currently under review by the European Medicines Agency (EMA).

In addition to naproxcinod, NicOx’s pipeline includes several nitric oxide-
donating NMEs, which are in development internally and with partners,
including Merck & Co., Inc. and Bausch + Lomb, for the treatment of select
cardiovascular indications, eye diseases and dermatological diseases.

NicOx S.A. is headquartered in France and is listed on Euronext Paris
(Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although
the Company believes its expectations are based on reasonable assumptions,
these forward-looking statements are subject to numerous risks and
uncertainties, which could cause actual results to differ materially from
those anticipated in the forward-looking statements.

For a discussion of risks and uncertainties which could cause actual
results, financial condition, performance or achievements of NicOx S.A. to
differ from those contained in the forward-looking statements, please refer
to the Risk Factors (“Facteurs de Risque”) section of the Document de
Reference filed with the AMF, which is available on the AMF website
(http://www.amf-france.org) or on NicOx S.A.’s website
(http://www.nicox.com).

CONTACTS

www.nicox.com

NicOx

Gavin Spencer – Vice President Business Development Tel +33 (0)4 97 24 53
00 – [email protected]

Media Relations

Financial Dynamics

Europe

Guillaume Granier (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Stéphanie Bia (France) – Tel: +33 (0)1 47 03 68 10 –
[email protected]

Jonathan Birt (UK) – Tel +44 (0)20 7269 7205 – [email protected]

United States

Robert Stanislaro – Tel +1 212 850 5657 – [email protected]

Irma Gomez-Dib – Tel +1 212 850 5761 – [email protected]

NicOx S.A.,

Les Taissounières – Bât HB4 – 1681 route des Dolines – BP313,
06906 Sophia Antipolis cedex, France. Tel. +33 (0)4 97 24 53 00 – Fax +33
(0)4 97 24 53 99

This information is provided by HUGIN